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1 General introduction 
All dairy fermentations are based on usage of lactic acid bacteria (LAB) for 
acidification and development of flavors. Taxonomically, LAB are divided into 11 
genera, but only four, Lactobacillus, Streptococcus, Lactococcus and Leuconostoc 
are commonly used in dairy starter cultures (Hassen and Frank, 2001). Lactobacilli, 
a large and diverse group of LAB, and have been isolated from many sources 
including all parts of the human GI tract (Greene & Klaenhammer, 1994). 
Lactobacillus cells are typically rod-shaped with sizes ranging from 0.5-1.2 x 1.0-10 
µm; under certain growth conditions they can look almost coccoid-like. They are 
nonsporing cells, Gram-positive, catalase negative, mainly thermophillic bacteria. The 
optimal growth temperature is between 30-40°C. They are also aciduric with a pH 
optimum of 5.5-5.8. The genus Lactobacillus has been divided into three groups 
based on fermentation end-products. Group 1: obligately homofermentative 
lactobacilli, e.g. L. delbrückii subsp. lactis, L. delbrückii subsp. bulgaricus, L. 
helveticus, L. acidophilus, L. gasseri and L. johnsonii; Group 2: facultative 
heterofermentative lactobacilli, e.g. L. casei, L. paracasei subsp. paracasei, L. 
rhamnosus, and L. plantarum and Group 3: obligately heterofermentative lactobacilli, 
e.g. L. brevis, L. fermentum, L. kefir and L. reuteri. Some lactobacilli are used as 
probiotics, e.g. L. acidophilus, L. johnsonii, L. gasseri, L. casei, L. rhamnosus, L. 
plantarum (Abe et al., 1995; Ishibashi and Yamazaki, 2001). Probiotics have been 
defined as ‘‘live microbial food supplements which beneficially affect the host by 
improving microbial balance of the intestine’’ Fuller, 1989; Sanders, 1998; Tannock, 
1999). Most probiotics are lactic acid bacteria (LAB) (Lee and Salminen, 1995) and 
probiotic products are considered to be safe and have GRAS (Generally Regarded 
As Safe) status. There are differing degrees of evidence supporting the confirmation 
of such effects. Table 1 summarized a number of potential health benefits provided 
by probiotic bacteria. 
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Table 1: A number of health benefits of probioticsa 
 
a Compiled from Sanders & Huis in’t Veld,1999; Report of FAO/WHO, 2001; Ezendam et al., 2005; 
*The Consultation of FAO/WHO was not convinced that there is sufficient proof of a correlation 
between probiotics and specific anti-cancer effects.  
Target health 
benefit Probiotic Postulated Mechanism 
Lactase 
intolerance  
Lactase positive 
strains -Bacterial lactase acts on lactose in the small intestine 
Prevention of 
diarrhoea and 
resistance to 
enteric 
pathogenic  
 
Lactobacillus 
rhamnosus GG 
and 
Bifidobacterium 
lactis BB-12 
- Adjuvant effect increasing antibody production 
- Systemic immune effect 
- Colonization resistance 
- Alteration of intestinal conditions to be less favorable for 
pathogenicity (pH, SCFA, bacteriocins) 
Helicobacter 
pylori infection 
and 
complications (B 
gastritis, peptic 
ulcers and gastric 
cancer) 
L. johnsonii La1; 
L. gasseri OLL 
2716  
-Growth inhibition  
- Decreasing urease enzyme activity necessary for the 
pathogen to remain in the acidic environment of the 
stomach  
Inflammatory 
diseases and 
bowel 
syndromes 
 
-The intestinal microflora plays a critical role in inflammatory 
conditions in the gut, and potentially probiotics could 
remediate such conditions through modulation of the 
microflora. 
Anti-colon 
cancer* effect 
L. casei Shirota;  
L. rhamnosus GG 
and LC-705 and 
bifidobacteria ; 
Propionibacterium  
-Modify the gut flora leading to decreasing glucuronidase 
and carcinogen levels  e.g. carcinogenic aflatoxin in the 
lumen  
 
Mucosal 
immunity 
L. casei Shirota; 
B. lactis HN019 
and L. rhamnosus 
HN001 
-Modify immune parameters; increased natural killer (NK) 
activity ; enhance the innate immune response;  
-Strengthening of non-specific and antigen-specific defense 
against 
infection and tumors 
- Adjuvant effect in antigen-specific immune responses 
- Regulating/influencing Th1/Th2 cells, production cytokines 
Allergy L. rhamnosus GG; B. lactis BB-12 
-Modulate the immune response and prevent onset of 
allergic diseases.   
- Prevention of antigen translocation into blood stream 
 
Cardiovascular 
disease 
 
lactobacilli 
- Assimilation of cholesterol by bacterial cell 
- Alteration of activity of bile salt hydrolase enzyme 
- Antioxidative effect 
Urogenital tract 
disorders 
(Bacterial 
vaginosis (BV); 
Yeast vaginitis; 
Urinary tract 
infections 
Lactobacillus 
acidophilus 
-Adhesion to urinary and vaginal tract cells 
-Competitive exclusion; 
-Production hydrogen peroxide  
 
Use of probiotics 
newborn 
children  
Many probiotic 
products 
-Probiotic microorganisms could become primary colonizers 
that remain long-term 
   General introduction 
21 
 
It is irrational to expect that one strain of any probiotic bacteria can fulfill all of the 
aforementioned potential health benefits (Gilliland, 2001).  
For selection and establishment of probiotic strains, there are many of selection 
criteria listed in Table 2. 
 
 
Table 2: Selection criteria for probiotic strains 
Appropriateness  
 i. Accurate taxonomic identification 
 ii. Normal inhabitant of the species targeted: human origin for human probiotics 
iii. Nontoxic, nonpathogenic, GRAS status 
Technological suitability 
iv. Amenable to mass production and storage: adequate growth, recovery, 
concentration, freezing, dehydration, storage, and distribution 
v. Viability at high cell densities  
vi. Stability of desired characteristics during culture preparation, storage, and delivery 
vii. Provides desirable organoleptic qualities (or no undesirable qualities) when 
included in foods or fermentation processes 
viii. Genetically stable 
ix. Genetically amenable 
Competitiveness 
x. Capable of survival, proliferation, and metabolic activity at the target site in vivo 
xi. Resistant to bile 
xii. Resistant to acid 
xiii. Able to compete with the normal microflora, including the same or closely related 
species; potentially resistant to bacteriocins, acid, and other antimicrobials produced 
by residing microflora 
xiv. Adherence and colonization potential preferred 
Performance and functionality 
xv. Able to exert one or more clinically documented health benefits (e.g. lactose 
tolerance) 
xvi. Antagonistic toward pathogenic / cariogenic bacteria 
xvii. Production of antimicrobial substances (bacteriocins, hydrogen peroxide, 
organic acids, or other inhibitory compounds) 
xviii. Immunostimulatory 
xix. Antimutagenic 
xx. Anticarcinogenic 
xxi. Production of bioactive compounds (enzymes, vaccines, peptides) 
Source: Klaenhammer and Kullen, (1999) 
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For evaluation of newly discovered probiotics, the scheme of FAO/WHO (Fig. 1) may 
be useful (FAO/WHO, 2002). 
 
Fig. 1: FAO/WHO guidelines for the evaluation of probiotics in food 
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Phenotype characterization (e.g. fermentation profiles, temperature, pH tolerance) is 
not satisfactory for identification of closely related species. Genetic analysis based on 
accumulating information of ribosomal RNA sequences release a developing source 
for comparative identification of probiotic bacteria (Klaenhammer and Kullen, 1999). 
Phylogenic analysis of sequence-based typing system using conserved regions of 
the ribosomal RNA operon is the most powerful tool for identification of probiotic 
bacteria (O’Sullivan, 1999). ARDRA and PFGE are in addition considered as 
powerful techniques for comparative identification. Chapter I in the present study was 
specified for identification of LAB using molecular methods e.g. ARDRA, PFGE, and 
sequencing of the 16S rRNA gene to achieve accurate identification as the main 
criterion for selection as a probiotic. 
If the desirable action needs that bacteria must survive and grow in the 
gastrointestinal tract, then characteristics that enable them to survive and grow under 
these conditions must be measured e.g. bile salt as well as pH tolerance. In chapter 
II of this study, characterization of Lactobacillus strains concerning selection criteria 
for probiotics such as acid and bile salts tolerance, antimicrobial activity as well as 
antibiotic susceptibility as a safety factor was performed.  
For the ability of bacteria to establish themselves or grow in the intestine, it is 
important to consider the bile salt tolerance of selected strains (Gilliland, 2001). 
Therefore, resistance to bile salts is an important characteristic for the selection and 
establishment of a probiotic strain (Moser and Savage, 2001; Dussurget et al., 
2002). There are many theories, which explain the mechanism of bile salts tolerance 
(see introduction of chapter III). Generally bile salts are deconjugated first by 
intestinal bacteria before they are further metabolized, Fig. 2 (Batta et al., 1990; Hill 
1995).  
 
Fig. 2: The two predominant bacterial modifications of bile salts 
 R indicates the amino acid glycine; GCA: glycocholic acid; CA: cholic acid;  DCA: deoxycholic acid 
(adapted from De Boever and Verstraete, 1999) 
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Therefore, chapter III of the actual study is concerning with screening of Lactobacillus 
species for bile salt hydrolase activity and cloning, transformation and expression of a 
responsible gene in different Lactobacillus strains. 
Many other factors must also be considered for probiotic bacteria to survive in the 
product and after consumption in the consumer’s gastrointestinal tract. These include 
the physiologic state of the probiotic organisms added; the physical conditions of 
product storage, the chemical composition of the product to which the probiotics are 
added, as well as interactions of the probiotics with the starter cultures (Heller, 
2001). In addition, the inhibitory effect of bacteriophages and autolysis during 
industrial fermentation should be also considered. The greatest economic losses of 
dairy fermentations are caused by these obligate dairy starter cultures parasites.  
Therefore, chapter IV in the present study is focused on lysogeny and autolysis of 
lactobacilli caused by bacteriophages or their enzymes.  
The aim of this study was to evaluate putative probiotic lactobacilli isolated from 
different sources. The following goals were set:  
I) Isolation and identification of some lactobacilli by using molecular biological 
methods was performed. 
II) Characterization of Lactobacillus strains through probiotic selection criteria 
(acid tolerance, bile salts resistance and antimicrobial activity). Also, a 
safety assessment of some Lactobacillus isolates. 
III)Cloning, transformation and expression of a conjugated bile salt hydrolase 
gene (cbh) in different Lactobacillus strains. 
IV) Lysogeny and autolysis of lactobacilli as well as analysis of a template 
phage of Lactobacillus gasseri 
 
 
   Materials and Methods 
25 
 
2 Materials and Methods 
2.1 Bacterial cultures and growth conditions 
Lactic acid bacteria, Escherichia coli strains and phages used in this study are listed 
in Table 3 A ,B, C. Lactobacillus were grown in MRS medium with glucose or lactose 
at 37°C. E. coli strains were routinely grown in LB medium at 37°C.  Stocks from all 
strains were preserved at -80°C in 30% glycerol. The respective recombinant strains 
were propagated and maintained as above but with recommended antibiotic 
supplements (Table 4). 
 
Table 3: Bacterial strains used in this study 
A) Lactic acid bacterial strains 
No Strains Source Synonym 
1 Lactobacillus acidophilus BfEL 92015  
2 Lactobacillus johnsonii BfEL 92170  
3 Lactobacillus amylovorus BfEL 92203 DSM 20552 
4 Lactobacillus brevis BfEL 92026  
5 Lactobacillus brevis BFEL 92027  
6 Lactobacillus gasseri  BfEL 92075       DSM 20243  
7 Lactobacillus gasseri BfEL 92075-1 This study  
8 Lactobacillus gasseri BfEL 92075-2 This study  
9 Lactobacillus gasseri NCK102-ADH Raya et al.,1989  
10 Lactobacillus gasseri NCK102 Raya et al.,1989  
11 Lactobacillus plantarum BfEL 92122  
12 Lactobacillus rahmnosus BfEL 92149  
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No Strains Source Synonym 
13 Lactobacillus casei  LK1 Meyer-Barton, 1995  
14 Lactobacillus acidophilus BfEL 92006 ATCC10697 
15 Lactobacillus johnsonii BfEL 92204 DSM 20553 
16 Lactobacillus plantarum BfEL 92265 DSM 20174 
17 Lactobacillus rahmnosus BfEL 92146 DSM 20178 
18 Lactobacillus brevis BfEL 92113 DSM 20197  
19 Lactobacillus reuteri BfEL 92126 DSM 20016 
20 Lactobacillus delb. subsp. bulgaricus BfEL 92067 ATCC 12278 
21 Lactobacillus delb. subsp. lactis BfEL 92237 DSM20072 
22 Lactobacillus plantarum (A) This study  
23 Lactobacillus plantarum (C) This study  
24 Lactobacillus plantarum (D) This study  
25 Lactobacillus plantarum (E) This study  
26 Lactobacillus fermentum IS1 This study  
27 Lactobacillus plantarum IS2 This study  
28 Lactococcus  lactis IS5 This study  
29 Streptococcus thermophilus IS6 This study  
30 Lactococcus  lactis IS7 This study  
31 Lactococcus  lactis IS8 This study  
32 Lactococcus  lactis IS9 This study  
33 Lactobacillus plantarum IS13 This study  
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No Strains Source Synonym 
34 Lactobacillus fermentum IS1 This study  
35 Lactobacillus fermentum IS15 This study  
36 Lactobacillus fermentum IS16 This study  
37 Enterococcus saccharinimus IS8 This study  
38 Lactobacillus fermentum IS12 This study  
39 Leuconostoc mesenteroides IS14 This study  
40 Lactobacillus paracasei ISO1 This study  
41 Lactobacillus rhamnosus ISO2 This study  
42 Lactobacillus paracasei ISO3 This study  
43 Lactobacillus rhamnosus ISO4 This study  
44 Lactobacillus rhamnosus ISO5 This study  
45 Lactobacillus rhamnosus ISO6 This study  
46 Lactobacillus rhamnosus ISO7 This study  
47 Enterococcus gallinarum ISA1 This study  
48 Enterococcus saccharolyticus ISA2 This study  
49 Enterococcus saccharolyticus ISA3 This study  
 
B) E. coli Genotype Source 
1.  Easypore 
F', ara D139 (ara, leu)7697,  lacX74, galU, 
galK,  mcrA -(mrrhsdRMS-mcrBC), rpsL, dor, 
80dlacZ M15, endA1, nupG, recA1. 
Eurogentec,  
Belgium 
2. JM109 
F‘traD36 lacIq ∆(lacZ)M15 pro A+ B+ / e14- 
(McrA)∆(lac-proAB)thi gyrA96 (NaIr )endA1 
hsdR17(rk- mk+ )reIA1 supE44 recA1 (1) 
Stratagene, 
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3. Novablue 
endA1 hsdR17(rK12– mK12+) supE44 thi-1 
recA1 gyrA96 relA1 lacF’[proA+B+ 
lacIqZM15::Tn10 (TcR)] 
 Novagen, 
C) Phages 
Phage Characteristics   Reference 
ФLbgas1 Temperate, isometric, contractile tail, 44kb, pac-
type This study 
ФADH Temperate, isometric, , 44kb, cos-type Raya et al., 1992 
 
2.2 Media 
LB- Medium (E. coli):       Pepton from casein                  10.0 g/l 
          Yeast extract                                5.0 g/l 
          NaCl                      5.0 g/l 
          pH 7.0 ±0.2 
   MRS-Medium (Lactobacillus):    Peptone from casein                            10.0 g/l 
                   Beef extract                     8.0 g/l 
                                                          Yeast extract                                         4.0 g/l 
                                                          Glucose                              20.0 g/l 
                                                          K2HPO4                                               2.0 g/l 
                                                          Di-ammonium hydrogen citrate                 2.0 g/l 
                                                          Sodium acetate                               5.0 g/l 
                                                          MgSO4. 7H2O                               0.2 g/l 
                                                          MnSO4. 5H2O                              0.04 g/l 
                                                          Tween80                                                    1.0 g/l 
For solid media, 15 g agar per liter of broth media were added 
2.3 Additives 
 Antibiotics and other additives used for the media during this study 
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Table 4: Antibiotics and additives used in this study 
Antibiotics & 
Additives 
Final concentration in medium for 
E. coli                        Lactobacillus 
Dissolving 
agent 
Ampicillin 200 µg/ml                             - H2O dest. 
Erythromycin 150 µg/ml                     5-10 µg/ml Ethanol 
Chloramphenicol 15 µg/ml                       5-10 µg/ml Ethanol 
Tetracycline 12.5 µg/ml                            - 50% Ethanol  
Kanamycin  50  µg/ml                              - H2O dest 
IPTG 0.5 mM                                 - H2O dest 
X-Gal 40 µg/ml                               - DMFa 
Mitomycin C -                                 0.1-1.0 ug/ml H2O dest 
Ox- bile   -                                    0.1-3% H2O dest 
TDCAb 0.5%                                   0.5% H2O dest 
GDCAc 0.5%                                   0.5% H2O dest 
a) Dimethylformamid; b) Taurodeoxycholic acid; c) Glycodeoxycholic acid 
Table 5: Plasmids used in this study 
No Plasmid Description Source 
1 pBluescriptII    
SK+ (pBSK) 
ColE1, amr, lacZ, α-complementation Stratagene, 
Germany 
2 PGEM-T-
easy vector  
ColE1, amr, lacZ, α-complementation Promaga, USA 
3 pCAT cat194 cloned in pGEMT_Easy (Promega 
,  Germany) 
A. Geis 
(personal 
Communication 
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4 pL120 Cloning shuttle vector, amr, emr S. Mudadda 
(personal 
Communication 
5 pS1 cbh+ cloned into pGEM-T-easy vector This study 
6 pS2 cbh+  cloned into pBluescript IISK+ vector This study 
7 pS3A cbh+ in pL120, emr, amr This study 
8 pL9-1 3.7 kb SacI fragment(cbh+,rep+;mob+) in 
pBSK+ ; amr 
This study 
9 pL11 blunted Cat194 gene in pL9-1;  amr; cmr This study  
10 pL14 cbh+ in pGKV2; emr; cmr This study  
 
2.4 Isolation of lactic acid bacteria  
Lactic acid bacteria were isolated from different sources as some Egyptian dairy 
products (Laban rayb, Kariesh and mish cheese) as well as from four faeces samples 
from two twin babies at the age of 3 and 4 months. The isolation was performed by 
standard microbiological procedures. As selective media MRS-agar was used for 
isolation of LABs from the dairy products and AMC agar for the isolation from babies’ 
faeces. The incubation was performed at 37°C under anaerobic conditions. Once 
single colonies were obtained they were inoculated in MRS broth or TPY broth and 
after growth, the cultures were diluted and tested for purity on a suitable agar 
medium. In total, 66 isolates were obtained from Egyptian dairy products and 40 
isolates from each baby. The purity of the active cultures was also ascertained by 
microscopic examination 
2.5 Mini-scale isolation of chromosomal DNA from lactobacilli  
According to Leenhouts et al., 1990  
2.5.1 Reagents 
 1M DL-thereonin  
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 Solution A: (20% sucrose; 10 mM Tris-HCl (pH 8.0); 50 mM NaCl. 
 5 mg/ml lysozyme 
 10% SDS 
 1500 U/ml mutanolysin 
 20 mg/ml proteinase K 
 5mg/ml RNase A 
 phenol 
 chloroform / isoamylalcohol (chl/iaa-24:1) 
 3M Na-Ac (pH 5.2) 
 1XTE Buffer : (10 mM Tris (pH 8.0);1 mM EDTA) 
2.5.2 Procedure 
Overnight cultures of lactobacilli were diluted (1%) in MRS broth containing 40 mM 
DL-threonin and incubated at 37°C until O.D620nm=0.6. Cells from 5-10 ml growing 
cultures were collected in 2 ml eppendorf tubes. The pellets were resuspended in 1 
ml solution A, 20 µl lysozyme, and 20µl mutanolysin were added. The resuspended 
cells were frozen at -80°C for 30 min, thawed and incubated at 37°C for 30 min. 20 µl 
proteinase K and 50 µl were added, and incubation was continued at 60°C until the 
mixture was clear. 500 µl phenol and 500 µl of chloroform:isoamyl alcohol (24:1) 
were added and mixed by frequent inversions. The samples were centrifuged at 5 
min and the aqueous phase was transferred to a new tube and extracted with 500µl 
of chloroform : isoamyl alcohol (24:1) 2 times. The DNA was precipitated by adding 
50µl 3M NaAc and one volume of isopropanol. The DNA pellet thus obtained was 
recovered after centrifugation at 14,000 rpm, washed with 70 percent ethanol and 
dried at RT for 10 min. DNA was finally dissolved in 150 µl TE buffer (pH 8.0) 
supplemented with 5 µl RNase A.  
2.6 Plasmid Miniprep for gram positive bacteria  
As protocol of Macherey & Nagel; Modified by S. Lick (personal communication) 
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2.6.1 Reagents 
Solutions A1, A2, A3, A4, AW and AE (included in the Nucleospin plasmid kit) 
Mutanolysin solution  :   5000 U/ml in double distilled H2O 
Proteinase K solution  : 100 mg/ml in double distilled H2O  
Lysozyme solution  : 50 mg/ml in double distilled H2O  
Phenol   : Saturated with 3 M NaCl 
Chloroform/isoamyl alcohol  (24:1; volumetric) 
2.6.2 Procedure   
-Cells from 3 to 6 ml culture propagated to OD620=0.6-0.8 were collected in 2 ml 
Eppendorf tube by centrifugation. The cell pellets were washed with sterile D.D.W, 
recentrifuged and resuspended in 250µl solution A1. Solutions of lysozyme (25 µl) 
and mutanolysin (5 µl) were also added. The cells can be stored at -80°C. 
-The cells were incubated at 37°C for 1 h. 
-Solution A2 (250 µl) was added.  The cells were mixed (for not more than 5 min) by 
inversion until the cells lysed and the solution was clear. 
-Ice cold solution A3 (300 µl) was added and the contents mixed and placed on ice 
for 5 min. 
-The tubes were centrifuged (full speed) for 12 min and the upper phase was 
transferred to a fresh Eppendorf tube (2 ml).  
- 25 µl proteinase K was added, followed by incubation at 37°C for 15 to 30 min. 
-Equal volumes of phenol and chloroform : isoamylalcohol (24:1) were added to the 
upper phase. The contents were mixed well by inversion. 
-The tubes were centrifuged (full speed) for 5 min. 
-The clear upper phase was transferred to a purification column centrifuged at full 
speed for 1 min. 
-The flow through in the collection tube was discarded. 
-Solution AW (500 µl) at 50°C was added to the column and centrifuged.  The flow 
through in collection tube was discarded.  
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Solution A4 (600 µl) was added and centrifuged (full speed, 1 min).  The flow through 
in the collection tube was discarded. 
- Finally, the purification column was transferred to a fresh Eppendorf (1.5 ml) tube.  
Solution AE (60 µl) was added to the column and DNA was eluted by centrifugation 
and stored at 4°C or –20°C until further use. 
-An aliquot of 5 to 10 µl of the plasmid DNA was run on Agarose (0.8%) gel to 
ascertain the concentration and purity of the DNA.  
2.7 NucleoSpin plasmid quickpure protocol for E. coli (Macherey & Nagel, 
Germany)  
2.7.1  Procedure 
-The overnight grown culture (1 to 5 ml) was harvested and centrifuged at 11,000 x g 
for 30 sec at 4°C to pellet the bacterial cells.  The supernatant was then discarded. 
-The pellet was carefully resuspended in 250 µl of buffer A1. 
- 250 µl of buffer A2 was added to the suspension.  The content was gently mixed by 
inverting the tube 6 to 8 times and incubated at room temperature for 5 min. 
-An aliquot of 300 µl of buffer A3 was added to the suspension and mixed gently by 
inverting the tube 6 to 8 times. 
-The suspension was centrifuged at 11,000 x g in a microcentrifuge for 5 min at room 
temperature. 
-NucleoSpin column was placed in a fresh 2.0 ml collection tube and the supernatant 
was loaded into the spin column The supernatant was then centrifuged at 11,000 x g 
for 1 min at room temperature and the flow through was discarded.  
-450µl of buffer AQ (with ethanol) was added to the NucleoSpin column and 
centrifuged at 11,000 x g for 3 min at room temperature.  The flow through was 
discarded.  
-The NucleoSpin column was placed in a fresh 1.5 ml microcentrifuge tube.  The 
DNA was eluted from the columns with 50 to 100 µl of buffer AE (5 mM Tris-HCl, pH 
8.5). 
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2.8 ARDRA  
2.8.1 DNA preparation  
Total DNA was prepared according to as aforementioned  
2.8.2 Enzymatic amplification of rDNA 
For PCR, universal primers UP68 and UP69 (Vaneechoutte et al., 1992) were used 
to amplify a fragment (approx. 2.4 Kb) encompassing the 16S, the spacer region and 
part of the 23S rDNA. Reactions were carried out in sterile 0.2 ml tubes with final 
reaction volume of 50µl. Reaction mixture contained of 2X PCR mix [Tag DNA 
polymerase (recombinant) in reaction buffer, MgCl2 and dNTPs (dATP, dCTP, 
dGTP, dTTP)] 25 µl, 10 pmol of each primer, and 22.5 µl of sterile H2O and 1.9 µl of 
target DNA. PCR amplification was carried out in a Mastercycler 5333 (Eppendorf, 
Hamburg, Germany) where tubes were heated to 93ºC for 5min and amplification 
was started. PCR conditions were 1 min. at 92ºC, 1:30 min. at 58ºC and 2:20 min. at 
72ºC for 35 cycle, completed by a terminal elongation step for 10 min at 72ºC  
2.8.3 Restriction analysis  
Restriction digests were carried out in volumes of 20 µl containing incubation buffer, 
10U of restriction enzyme and 2-5 µl of PCR product at appropriate temperatures. 
Restriction fragment patterns were analyzed by agarose- gel –electrophoresis  
2.9 Pulsed Field Gel- Electrophoresis (PFGE) 
The PFGE was carried out for some isolates and some type strains as follows: 
2.9.1 Cultivation of cells: 
Fresh over night culture were diluted (1%) in 5 ml of MRS broth containing 20mM 
DL- Threonin and cells were grown till OD620  0.5-1 (not higher than OD 1). Cells 
were harvested by centrifugation in a 2 ml Eppendorf tube and washed 2 times with 
0.05M EDTA pH8.5. Cell pellets were kept at -20ºC till used. 
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2.9.2 Insert preparations: 
100µ 0.05M EDTA pH8.5 was added to each pellet and the cells were resuspended 
carefully. For the inserts, low melted agarose 1% in 0.05M EDTA (pH8.5) was 
dissolved and stored at 50ºC till used. 500µ 1% agrose was filled in 2 ml Eppendorf 
tubes (placed in 50ºC water-bath) and 75-100µ of cell suspensions were added, 
mixed carefully and placed in 50ºC water-bath ( Turbidity of the solutions should be 
between 4 to 5 according to McFarland-Standard; Biomerieux). 
2.9.3 Tray preparation: 
 The tray (Bio-Rad system) was rinsed well with d. d. water and cleaned with ethanol, 
screwed well and placed on the table, the lower side in front. 500µl of the agarose-
cell suspension was poured into two insert-slots (each 250µ). The tray was placed 
for 10min at -20ºC for polymerization. The inserts were transferred in 2 ml Eppendorf 
tubes containing 1.5 ml lysozyme solution and digested at 37ºC for 24 hrs. 
2.9.4 Preparation of the lysozyme solution: 
1.67µl N-Lauroylsarcosine (stock solution 30%) 
2.0 mg Lysozyme 
20 U Mutanolysin 
1000µl 0.05 M EDTA pH 8.5 
2.9.5 Proteinase K digest :  
NDS-Buffer  
10 µl                         1M Tris HCl pH 8.0 
100 µl                       10% SDS 
890 µl                        0.05 M EDTA pH 8.5 
 
 Proteinase K solution: 1.5 mg Proteinase K + 1 ml NDS buffer. 
The inserts were moved into 2 ml Eppendorf tubes containing 1.5 ml of proteinase K 
solution and incubated at 50ºC. After 20-30 min the Eppendorf tubes were opened 
and closed for equalization of pressure and the incubation was continued for at least 
24 hrs.  
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 After Proteinase- K digest, inserts were washed with 0.05 M EDTA, pH 8.5 for 30 
min at room temperature (6-7 times). Inserts were stored in 0.05 M EDTA, pH 8.5 at 
4ºC. 
2.9.6 Digestion with restriction enzymes: 
-2 stripes, each 3 mm width were cut from the inserts, transferred into Eppendorf 
tubes filled with 300µl TE-buffer and incubated at 4ºC for 30 min. 
- The TE-buffer was replaced by 200µl of RC-buffer (180µl TE-buffer + RC buffer 
10X) were added, the strips were incubated at 4ºC for 30 min. 
-For digestion, RC-buffer was replaced by 200µl of RCE (180µl TE-buffer + RC buffer 
10X +10U Enzyme). The samples were incubated at 37ºC overnight. 
2.9.7 Pulsed field gel electrophoreses with inserts:   
-1.1% low melt-agarose in 0.5x TBE-buffer was prepared and cooled down to 50ºC 
-The gel-trayer was cleaned with ethanol, a comb with 10 slots was placed and 100 
ml of the previous gel was poured into the tray. 
- After solidification of the agarose the comb was removed and the slots were filled 
with TBE-buffer.  
-The gel strips were placed into the bottom of slots, the TBE-buffer was removed 
carefully by suckling out with a tissue and the inserts were fixed by pouring 0.8% low 
melt agarose into each slot. 
- PFGE was performed at 175V, 24h, at 14°C. 
-After running time, the gel was stained in ethidium bromide and was checked by UV 
and photographed. 
2.10  Acid tolerance test 
Acid tolerance was evaluated by growing the strains in MRS broth adjusted to acidic 
pH 3.5 and 2 by adding HCl and nonacidified MRS broth pH 6.5 and incubating at 
37ºC for 90 min. Samples were collected during incubation period intervals 0, 30, 60, 
90 min   and plate counts were done using MRS agar and the pour plate technique. 
2.11 Bile salt tolerance test 
Overnight cultures were diluted into 10 ml MRS broth medium containing different 
concentration (0, 0.1, 0.3, 0.5, 1, and 3%) of the ox-gall bile salts, TDCA or GDCA, 
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respectively. Samples were incubated at 37°C and growth was measured by 
following the O.D620nm using the photometer Nanocolor 250D (Macherey-Nagel, 
Dürem, Germany). 
2.12   Bile salt hydrolase activity assay  
The Lactobacillus strains were tested for bile salt hydrolase activity with a plate assay 
on MRS agar supplemented with 0.5% sodium salts of taurodeoxycholic acid (TDCA) 
or 0.5% sodium salts of glycodeoxycholic acid (GDCA) (Scott, 2001). Overnight 
Lactobacillus cultures were diluted and plated onto MRS agar containing TDCA or 
GDCA. The plates were incubated anaerobically at 37°C for 48h. cbh activity was 
indicated by deoxycholic acid precipitate around the colonies. 
2.13 Antimicrobial activity test 
The antimicrobial activity test was performed by an agar diffusion test. The indicator 
strains were subcultured in tryptic soy broth. 100µl of indicator bacteria were plated 
on Muller-Hinton agar plates. Plates were air dried for 15 min and discs impregnated 
with 10µl of lactobacilli cultures or 30 µl of lactobacilli spent medium were positioned 
on them. After incubation at 37ºC for 24 hrs, the diameter of inhibition zones was 
measured. (Chang et al., 2001)      
2.14 Antibiotic susceptibility test: 
 Antibiotic susceptibility tests of Lactobacillus sp. were performed using the disk 
diffusion method according to the National Committee for Clinical Laboratories 
Standard (NCCL1997). Overnight cultures were prepared in MRS broth and freshly 
diluted 1:10 in MRS broth; 0.1ml of each diluted culture was plated onto Mueller-
Hinton agar plates (Chang et al., 2001) as standard medium for diffusion tests. The 
plates were allowed to stand for 30min at RT prior to dispensing antibiotic-containing 
discs using the Oxoid disc dispensing system. The plates were incubated 
anaerobically at 37ºC for 24h. Results (average of two determinations) were 
expressed in terms of resistance (R); moderate susceptibility (MS) and susceptibility 
(S); according to the interpretative standards described by Charteris et al., (1998) 
(Table 6).  
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Table 6: Antimicrobial agents and associated interpretative zone diameters for disc 
diffusion antibiotic susceptibility testing 
 
Group 
                                         
Antimicrobial agents Interpretative zone 
diameters (mm)* 
Name             disc conc.(µg)   R        MS          S 
 
І- Inhibitors of cell wall 
synthesis 
Ampicillin                10 
Cefotaxime             30 
Vancomycin            30 
Methicillin                 5      
≤12     13-15    ≥16 
≤14     15-22    ≥23 
≤14     15-16    ≥17 
---       10-13    ---- 
 
 
 
II- Inhibitors of protein 
synthesis 
Gentamycin            10 
Kanamycin             30 
Streptomycin          10 
Tetracycline            30 
Chloramphenicol    30 
Erythromycin          15 
Lincomycin             15 
Neomycin               30 
≤12      ----       ≥13 
≤13     14-17    ≥18 
≤11     12-14    ≥15 
≤14     15-18    ≥19 
≤13     14-17    ≥18 
≤13     14-17    ≥18 
---       18-20    ---- 
---       15-17    ---- 
III- Inhibitors of nucleic 
acid synthesis 
Ofloxacin                 5  ≤13     14-18    ≥19 
* Susceptibility expressed as resistance (R); moderate susceptibility (MS) or susceptibility (S) 
 
2.15 Polymerase chain reaction (PCR) 
Polymerase chain reaction process was performed using a thermocycler 
(Mastercycler 5333) Eppendorf AG- Germany.  All primers used were listed in Table 
7 and all PCR programs were listed in Table 8. 
2.15.1 PCR reaction: 
26 µl deionised water 
1µl (10 pmol) primer1 
1µl (10 pmol) primer1 
20µl PCR master-mix  
 
2.15.2 Purification of PCR product:  
All PCR products were purified by QIA quick spin kits pursued from QIAGEN GmbH – 
Germany, before using in ligation reactions  
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Table 7: List of primers used 
Primer  
Name 
Tm 
(°C) 
Target  
Gene 
 
Primer sequence(5`      3`) 
Amplicon 
size (bp) Reference 
UP68 66.1 16S- 
23S  
rRNA 
TGG CTC AGA TTG AAC GCT GGC 
GGC 2400 Vaneechoutte 
et al., 1992 UP69 66.8 CCT TTC CCT CAC GGT ACT GGT 
DG74 60.3 
16S  
rRNA 
AGG AGG TGA TCC AAC CGC A 
1600 
Greisen et al., 
1994 
16SF 58.8 TTG GAG AGT TTG ATC CTG GCT C Carroll et al., 2000 
cbh1 61.9 
cbh 
GAA GAA TTC GCT ATT GAA GCA 
ATC ACG 
1392 This study* 
 cbh2 61.9 GAA GAA TTC AAA CCC AAC TTA CCA TCG 
hol-lys1 58.4 holin- 
lysin  
 
CGC AAG AAG GTT AAA CGG TTA G 
1477 This study* 
hol-lys2 59.8 CCA GAG AAA CAT CTC CAG AGC 
LactoF 56.9 16S  
rRNA 
TGG AAA CAG RTG CTA ATA CCG 
231-233 Byun et al., 2004 LactoR 57,3 GTC CAT TGT GGA AGA TTC CC 
LactoF 56.9 
16S  
rRNA 
TGG AAA CAG RTG CTA ATA CCG 
1600 
Byun et al., 
2004 
LbLMA1 50.1 CTC AAA ACT AAA CAA AGT TTC Duberner et 
al., 2002 
Im26-f 59.8 16S  
rRNA 
GAT TCT GGC TCA GGA TGA ACG 
1417 
 
Kaufmann et 
al., 1997 Im3-r 57.6 CGG GTG CTN CCC ACT TTG ATG 
St1 54.7 
16S  
rRNA 
TTA TTT GAA AGG GGC AAT TGC T 
279 Furet et al., 2004 
St2 57.9 GTG AAC TTT CCA CTC TCA CAC 
R= A, G    *Primers were designed using OMIGA sequence analysis or DS gene software. All primers 
were delivered from MWG –biotech company Germany. 
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Table 8: PCR programs used in this study 
Primer cbh1/ 
cbh2 
hol-lys1/ 
hol-lys2 
Up68/ 
Up69 
DG74/16SF Im26-f/Im3-f LactoF/ 
LactoR 
LactoF/ 
LbLMA
St1/ 
St2 
Initial denaturation 94°C 
2 min 
94°C 
2 min 
93°C 
5 min 
93°C 
5 min 
94°C 
5 min 
95°C 
15 min 
95°C 
5 min 
94°C 
5 min 
Denaturation 94°C 
30 sec 
94°C 
30 sec 
92°C 
1 min 
92°C 
1 min 
94°C 
1 min 
95°C 
15 sec 
95°C 
20 sec 
94°C 
1 min 
Annealing 57°C 
40 sec 
54°C 
40 sec 
58°C 
1:30 min 
55°C 
1 min 
60°C 
2 min 
64°C 
1 min 
54°C 
1 min 
55°C 
2 min 
Elongation 72°C 
1:20 
72°C 
1:20 min 
72°C 
2:20 min 
72°C 
2 min 
72°C 
2 min 
72°C 
30 sec 
72°C 
2 min 
72°C 
2 min 
Total cycles 31 31 35 35 35 39 31 40 
Final elongation 72°C 
10min 
72°C 
10min 
72°C 
10min 
72°C 
10min 
72°C 
10min 
72°C 
3.5 min 
72°C 
7 min 
72°C 
10 min 
Holding temperature 4°C 4°C 4°C 4°C 4°C 4°C 4°C 4°C 
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2.16 Molecular weight markers   
- λStyI DNA containing the molecular weight bands of 19329, 7743, 6223,4254, 
3472, 2690, 1882, 1489, 925, 421 bp . 
 - DNA 100 bp ladder (Fermentas) was also used as a marker.   
2.17 AGAROSE GEL ELECTROPHORESIS 
Analysis of chromosomal and plasmid DNAs, PCR amplicons, restriction enzymes 
digests, was performed by agarose gel electrophoresis. Agarose gel (0.6 % - 1.5 %) 
was prepared by dissolving the appropriate quantities of agarose in 1x TAE buffer 
(pH 8.0) in a microwave oven. Ethidium bromide stock solution was added directly to 
molten agarose solution at a concentration of 0.5 µg/ml before pouring the gel. 
Before loading the samples were mixed with 6x loading buffer. After electrophoresis 
DNA fragments in the agarose gel containing ethidium bromide were visualized and 
photographed using a Gel Doc TM XR system and quantity one software (Bio Rad). 
2.17.1 Reagents 
Tris acetate-EDTA (TAE) buffer (pH 8) 
Ingredients             g/1000 ml (10X) 
Tris base    48.4 
Na2-EDTA    7.45 
NaCH3COOH x 3H2O  (Na-acetat) 6.9 
pH adjusted to pH 8.0 with acetic acid. 
Sample buffer 
Ingredients                         g/100 ml  
0.5% bromophenol blue   0.05  
66% glycerol (w/v)   47.6 ml 
Distilled water   52.4 ml 
Staining solution  
Working solution of EtBr was prepared by adding 1 ml of stock solution of EtBr (0.5 
mg/ml) to one litre of distilled water to give a final concentration of 0.5 µg / ml.  
2.18 Molecular cloning and other gene manipulation techniques  
All the molecular biology techniques which include ligation, cloning, restriction 
digestion, purification of inserts by DNA gel extraction kits (MinElute, Qiagen), PCR 
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product purification (MinElute, Qiagen), plasmid minipreps, construction of plasmids 
etc. were performed according to protocols given by Sambrook et al., (2001) or the 
instructions of manufacturers. 
2.19 Transformation 
2.19.1 Preparation of competent cells of E. coli 
Competent cells of E. coli were prepared according to Sambrook et al., (2001) with 
modifications as follows: 
- 5 ml of overnight culture were diluted in fresh 250 ml LB broth in a 1L flask. The 
culture was incubated at 37°C with vigorous shaking on a rotary shaker until OD at 
620 nm reached 0.3-0.4. 
-The cells were harvested by centrifugation at 8,000 rpm for 10 min at 4°C.  All other 
steps were carried out aseptically on ice.  The medium was poured off and the pellet 
was resuspended in ice-cold sterile d. d. water. 
-The cells were recovered by centrifugation at 8,000 rpm for 10 min at 4°C and 
resuspended in 400 ml cold 10% glycerol, then collected by centrifugation at 8,000 
rpm for 10 min at 4°C. 
- The cells pellet was resuspended in ice cold 20 ml GYT medium (10% glycerol + 
0.125% yeast extract + 0.25 tryptone), harvested by centrifugation and resuspended 
in 1 ml GYT, then divided in 40 µl aliquots in eppendorf tubes and frozen directly in 
liquid nitrogen. Finally, the cells were stored in at -80°C for further use. 
2.19.2 Electroporation of E. coli (easy pores) with a Gene pulser (BioRad) 
- 40 µl of competent E. coli easy pores cells were mixed with 2µl ligation mix (DNA) in 
a microcenterfuge tube placed into ice bath 
- The cell-DNA mixture was transferred to a cold 0.1 cuvette and placed in the Gene 
Pulser cuvette holder. 
- Cells were treated with one pulse with the Gene Pulser set at 1.25kV and 25µlF. 
The pulse controller was set at 200 Ω. 
- The cells were immediately diluted with 950µl of SOC medium, then transferred to a 
test tube and incubated at 37ºC for 1 hr. 
- The cells were plated onto LB agar medium containing 100µg Ampicillin (Amp) 
120µg IPTG and 40µg x-gal per ml. 
- The plates were incubated at 37ºC overnight. 
- Transformants were identified by blue/white selection. 
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2.19.3 Transformation using heat shock (e.g. Nova-Blue) 
- 5 µl of the ligated DNA was added to 100 µl of competent cells and mixed gently by 
flicking.  Positive control was also set up to check for transformation efficiency. The 
mix was incubated on ice for about 30-45 min. 
-The tubes were then transferred to water bath maintained at 42°C and held for 
exactly 90 sec.  The tubes were rapidly transferred to ice and allowed to chill for 1-2 
min. 
-To the above mix, 900 µl of LB broth was added and mixed.   
-The tubes were incubated at 37°C for one hour on a rotary shaker to allow the 
bacteria to recover and express the antibiotic resistance. After incubation, 200 µl of 
transformation mix were spread evenly on LB agar plates with ampicillin (100 µg / ml) 
and incubated at 37°C for 16-20 hrs. 
-The transformants obtained on LB agar plates with ampicillin were inoculated into LB 
broth containing ampicillin and incubated in shaking incubator at 37°C for 12-16 hrs 
after which the cells were harvested and used for plasmid isolation.  
2.19.3.1 Reagents for blue and white screening   
X-Gal (5-bromo 4-chloro-3-indolyl-β-D-galactopyranoside) 
 0.5 g dissolved in 5 ml of DMF (dimethyl formamide). 
0.1 M IPTG (Isopropyl-1-thio-β-D-galactopyranoside) 
2.20 Electroporation of Lactobacillus strains  
Electroporation of L. casei and L. gasseri was performed according a protocol of B. 
Henrich (personal communication) and method of Varmanen et al., 1998
 
was used 
for L. rhamnosus with modifications as summarized in following flow charts.  
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2.20.1   Preparation of L. casei competent cells  
 
 
*EPB buffer: 
0.5 M Sucrose 
1 mM MgCl2 
7 mM potassium phosphate buffer pH7.2 
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2.20.2 Electroporation of L. casei  
             
 
*Note: In the case of using the chloramophenicol, less incubation time was used. 
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2.20.3 Preparation of L. gasseri competent cells  
                   
*3.5X SMEB buffer: 
952 ml 1M sucrose 
3.5 ml 1M MgCl2 
44.5 ml H2O 
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2.20.4  Preparation of L. rhamnosus competent cells  
 
* Electroporation buffer: 
0.5 M Sucrose 
7mM potassium phosphate (pH7.4)
 
1mM MgCl2 
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2.20.5 Electrotransformation of L. gasseri and L. rhamnosus 
            
Note: In the case of using the chloramophenicol, less incubation time was used 
2.21 Analysis of Transformants  
E. coli or Lactobacillus transformants isolated from respective growth media plates 
with appropriate antibiotic were subjected to plasmid minipreps.  The minipreps were 
analysed on agarose gel for the recombinant plasmid vector and the presence of 
desired insert in the vector was checked by digestion and nucleotide sequencing 
(whenever necessary). 
2.22 Segregational stability of the recombinant plasmids 
The stable maintenance of the plasmids pL11 and pL14 in Lactobacillus ssp under 
non-selective conditions was determined. Cultures were transferred daily into fresh 
MRS broth without antibiotics. Every 7 days cultures were plated onto MRS agar with 
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and without antibiotics. The differences between the total count on MRS agar and on 
MRS containing antibiotics indicated the stability of plasmids. 
2.23 Nucleotide sequencing  
Nucleotide sequencing of the clones produced in this study was done at MWG 
Biotech, German, using universal sequencing primers. Sequence analysis was 
carried out by using Molecular Biology softwares such as DNASIS, DS gene etc. 
2.24 Construction of clones   
Constructions of various recombinant plasmids are described in Chapter III (Results 
and Discussion).  
2.24.1 Cloning and Expression of the cbh gene in E. coli 
PCR amplicon of the cbh gene was purified and cloned into pGEM-T-easy vector as 
a PCR fragment directly and after digestion with EcoRI, and into pBluescriptII SK+ 
(pBSK). The ligation mixes were transformed into electro-competent cells E. coli easy 
pores. Transformants were detected by blue/white screening. 
2.24.2 Blunting and dephosphorylisation of DNA 
The DNAs digested with restriction enzymes were blunted using T4 polymerase as 
shown in Table 9 and the blunted vectors were dephosphorylated using SAP (Shrimp 
Alkaline phosphatase-Table 10). All reactions were carried out according to ´ 
instructions of suppliers. (Fermentas or Biolabs) 
Table 9: Blunting of DNAs for blunt –end ligations 
Blunting Reaction               Amounts 
Vector      PCR product 
5X Reaction buffer 4µl 4µl 
DNA 10µl 5µl 
2mMdNTP mix 1µl 1µl 
T4 DNA polymerase 1µl 1µl 
D. D. water 4µl 9µl 
Total 20µl 20µl 
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This reaction mix was incubated at room temperature for 5 min and the reaction was 
stopped by heating at 70°C for 10 min. For blunting of the PCR product the mixture 
was incubated at 37°C for 5 min then, at 12°C for 15 min and the reaction was 
stopped by heating at 75°C for 10 min.  
Table 10: Dephosphorylisation of blunted vectors 
Dephosphorylisation Reaction Amounts 
Reaction buffer        5µl 
Blunted DNA (vector) 28µl 
SAP (Shrimp Alkaline phosphatase)   1µl 
D. D. water 16µl 
Total 50µl 
This reaction mix was incubated at 37°C for 30 min. and the reaction was stopped by 
heating at 65°C for 15 min.   
 
2.25 Induction of Lysogenic Strains  
Lactobacillus strains propagated in MRS medium at 37ºC were treated with 
mitomycin C (MC) at different concentrations. The lysates were filtered through 
0.45µm Millipore membranes and checked with electron microscope. 
2.26 UV Induction 
The cells were suspended in 0.1 M MgSO4 and pumped through a quartz tube 
(internal diameter 1.3 mm length 75cm) placed under a laboratory UV lamp (Neve et 
al., 1998).  
2.27 Isolation of page particles 
The bacteriophage particles from strain L. gasseri BfEL 92075 were isolated from 
one liter of MC-induced lysate and purified through CsCl density gradient 
centrifugation according to procedure described by Sambrook et al., (2001).   
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2.28 Phage morphology  
Dialyzed phage concentrates were stained with 2% (w/v) uranyl acetate as described 
before (Neve et al., 1989). Electron micrographs were taken in an EM300 electron 
microscope (Fei-philips, Eindhoven, Netherlands) at an accelerating voltage of KV 
(Neve and Teuber, 1989).   
2.29 Phage and bacterial DNA purification 
Phage DNA was extracted from purified phage particles by proteinase K and phenol-
chloroform method of Sambrook et al., (2001). Isolation of chromosomal bacterial 
DNA was performed as described above.    
2.30 Restriction enzyme analysis 
Cleavages with restriction enzymes were carried out according to instructions of 
suppliers (Fermentas or Biolabs). Digests were loaded onto 0.6% and 1.5% agarose 
gels.  The gel pictures were applied to computer soft ware Quantity One, version 
4.5.2 (BioRad) and fragments size were estimated. In addition, heating of digests at 
74ºC for 5 min was done according to Quiberoni et al., (2003) 
2.31 Southern blot and DNA-DNA hybridization 
Southern blot and hybridization were performed after agarose gel electrophoreses 
of DNA digests according to a modified protocol of the DIG-system, Roche, 
Germany.  
2.31.1 Reagents for Southern hybridization  
DIG-DNA labeling kit (Roche) 
Hexanucleotide mix (10X conc.) 
DIG DNA labeling mix (10X conc.) 
Klenow enzyme 
250 mM HCl solution 
21 ml 37°C HCl, up to 1000 ml D.D.W 
Autoclaved at 121°C for 20 min 
Blotting transfer buffer   
0.4 M NaOH 
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SSC-buffer  
3 M NaCl  
300 mM Na-citrate 
pH 7.0 
Autoclaved 
20% SDS:  pH 7.2 (adjusted with conc. HCl).  
Wash buffer (room temperature) 
2X SSC  
0.1% SDS 
Five ml of 20% SDS was added to 100 ml of 20X SSC and the volume made 
up to 1000 ml with sterile D.D.W 
Wash buffer (68°C):  
0.1% SSC  
0.1% SDS 
Five ml of 20% SDS was added to 5 ml of 20X SSC and the volume made up to 1000 
ml with D.D.W 
4 M LiCl:  Lithium chloride (16.96 g) was dissolved in a final volume of 100 ml D.D.W 
and autoclaved. 
200 mM EDTA:  EDTA (7.45 g) was dissolved in 80 ml D.D.W.  The pH was adjusted 
to 8.0 and the volume was completed up to 100 ml.  The solution was autoclaved. 
Buffer 1 (10X):  0.1 M Malic acid; 0.15 M NaCl; pH 7.5. 
Malic acid (116.07 g) and NaCl (87.66 g) were dissolved in 800 ml D.D.W. The pH 
was adjusted to 7.5 with NaOH pellets.  The volume was made up to 1000 ml with 
D.D.W and the solution was autoclaved. 
Buffer 1 (1X):  Buffer 1 (10X) and distilled water were mixed in the ratio of 100:900. 
Wash Buffer:  Three ml of Tween 20 was made up to 1000 ml with Buffer 1 (1X). 
Buffer 2 (10X):  Fifty grams of blocking powder was dissolved in 450 ml buffer 1 (1X) 
at 70°C for 1 h.  The volume was made upto 500 ml with buffer 1 (1X).  The solution 
was autoclaved and stored at –20°C in the ratio 100:900. 
1 M NaCl (autoclaved).  
1 M Tris (pH 9.5, autoclaved). 
Buffer 3:  Solutions of 1 M NaCl and 1 M Tris (pH 9.5) were mixed in the ratio 
100:900.  Buffer 3 was freshly prepared and not autoclaved.  
DIG Easy Hybridization Solution (Roche). 
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CSPD (Roche): Disodium 3-(4-methoxyspiro {1,2-dioxetane-3,2’-(5’-chloro) tricyclo 
decan}-4-yl) phenyl phosphate. 
Anti-Digoxigenin-AP (Polyclonal sheep anti-digoxigenin, Fab-fragments, conjugated 
to alkaline phosphatase; Roche) 
2.31.2 Blotting 
The southern blotting was performed using a modified protocol described in the DIG 
System, Roche. The gel was immersed in 250 mM HCl with slight shaking for only 5 
min and washed in distilled water for 1 min. Blotting was done overnight with freshly 
prepared 0.4 M NaOH. The membrane was dried on filter paper and DNA was fixed 
by baking at 120°C for 30 min. The membrane was stored at 4°C until further use. 
 
2.31.3 Labeling of DNA probes  
For labeling the DNA to be used as probes in hybridization experiments, the DIG 
DNA labeling Mix (10X conc., Roche Diagnostics, GmBH) was used. 
 
2.31.3.1 Labeling procedure – DIG-labeled DNA probes. 
One to three micrograms of DNA in a maximum of 15 µl volume was denatured by 
heating for 10 min followed by chilling quickly on ice/salt mixture. 
The following were added to the freshly denatured DNA on ice:  
 Reagent     Volume  
 Hexanucleotide mix, 10X conc.  2 µl 
 DIG DNA labeling mix, 10X conc. 2 µl 
 Klenow enzyme    1 µl 
 Sterile D.D.W    Volume made up to 20 µl 
-The contents were mixed and spun shortly in a Microcentrifuge.  
-The contents were incubated overnight at 37°C. 
-The reaction was stopped by adding 2 µl of 200 mM EDTA (pH 8.0). 
-The DNA was reprecipitated by adding 2 µl of 4 M LiCl followed by the addition of 60 
µl of ice-cold ethanol.  The samples were stored at -20°C for 2 h or overnight or at –
70°C for 30 min. 
-The contents were centrifuged at 4°C for 15 min (14,000 rpm). 
-The supernatant was discarded and the pellet (invisible) washed with 100 µl of 70% 
ethanol. 
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-The DNA was air-dried, dissolved in TE (pH 8.0) and stored at –20°C until further 
use. 
2.31.3.2 Estimation of the efficiency of labeling 
The amount of labeled probes prepared by random priming method was estimated by 
comparing method.  In this method, a series of dilutions prepared from the DIG-
labeled probe were spotted directly on a membrane Table 11.  For comparison, 
known concentrations of a DIG-labeled control nucleic acid were spotted in parallel 
on the same membrane. 
Table 11: Preparation of serial dilutions of probe and control DNA 
Dilution Procedure Final concentration 
1 (1:20) 2 µl DNA + 38 µl TE- buffer, pH 8.0 0.25 ng 
2 (1:200) 5 µl (1:20) + 45 µl TE 25 pg 
3 (1:2000) 5 µl (1:200) + 45 µl TE  2.5 pg 
4 (1:20000) 5 µl (1:2000) + 45 µl TE 0.25 pg 
5 (1:200000) 5 µl (1:20,000) + 45 µl TE 0.025 pg 
6 (1:2000000) 5 µl (1:20,000) + 45 µl TE 0.0025 
 
One microlitre of each dilution was spotted in a line on a nylon membrane. In parallel, 
the corresponding dilutions of control DNA were spotted. 
The DNA was fixed by baking at 120°C for 30 min in a hot air oven. 
2.31.3.3 Detection of labeled DNA  
The membrane was incubated for a short time in buffer 1 containing 0.3% Tween 20. 
Blocking:  The membrane was shaken at room temperature in buffer 2 for 10 min.  
Incubation with antibody (anti-digoxigenin):  
 Five milliliters of buffer 2 was taken in a shallow disposable polystyrene tray.  One 
microlitre of antibody (anti-digogenin) was added and mixed.  The membrane was 
submerged fully in this antibody solution and manually shaken for 10 min. 
Removal of excess antibody:  
The excess antibody was removed by shaking the membrane vigorously in 50 ml 
buffer 1, containing Tween 20 (0.3%), for 5 min.  This washing was repeated twice. 
Incubation with CSPD:  
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 Membrane was laid in a fresh hybridization bag.  Alternatively, two adjacent ends of 
a pair of rectangular transparent sheets (larger size than the membrane) were heat-
sealed and the membrane placed inside.  Five microlitre of CSPD was added to 500 
µl of buffer 3 and mixed.  The CSPD solution was added to the membrane and 
spread uniformly by stretching over the hybridization bag.  The membrane (in 
hybridization bag) was incubated for 5 min at room temperature. 
The membrane was removed from the hybridization bag and dried on a filter paper. 
The membrane was sealed in a fresh hybridization bag or between two transparency 
sheets and incubated at 37°C for 15 min. 
Detection of hybridization signal:  The membrane was placed over an X-ray film in 
dark and left for 30 min.  Subsequently, the X-ray film was developed by shaking in a 
developing solution for 2 to 3 min, washed with distilled water and fixed by shaking in 
a fixing solution for 2 to 3 min (or until bands appear).  The processed X-ray film was 
later washed with tap water and dried. 
 
2.31.4 Hybridization of probe to DNA  
2.31.4.1 Pre-hybridisation:  
The hybridization buffer with DIG (20 ml) was forewarmed at 42°C. 
2.31.4.2 Denaturation of probe:   
The probe was denatured by cooking for 10 min and chilled immediately in ice bath 
for 2 to 5 minutes. Subsequently, the denatured probe was mixed with the 
hybridization buffer (60 ml). The nylon membrane was placed in the glass bottle with 
the hybridization buffer and incubated overnight at 42°C in a hybridization chamber. 
2.31.4.3 Washing  
The nylon membrane was removed from the hybridization chamber and washed in 
wash buffer (2XSSC, 0.1% SDS) at room temperature for 5 minutes.  This step was 
repeated twice with fresh wash buffer. 
2.31.4.4 Stringent washing  
The membrane was washed for 15 min in wash buffer (0.1XSSC, 0.1% SDS) at 68°C 
by shaking. This step was repeated twice. The membrane was equilibrated for 15 min 
in buffer 1 containing 0.3 per cent Tween-20. 
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2.31.4.5 Blocking 
 The membrane was incubated in buffer 2 with shaking at room temperature for 2 hr. 
2.31.4.6 CSPD incubation   
The membrane was laid in a hybridization bag.  Alternatively, two adjacent sides of a 
pair of rectangular transparency sheets larger than the size of membrane were heat-
sealed and the membrane placed inside. 20µl of CSPD was mixed in 2 ml of buffer 3.  
The CSPD solution was added into the hybridization bag and was evenly spread over 
the membrane by stretching over the hybridization bag. 
2.31.4.7 Antibody incubation 
Two microlitre of antibody was mixed with 20 ml of buffer 2 in a disposable 
polystyrene tray.  The membrane was placed in the antibody solution and shaken for 
30 min. 
2.31.4.8 Removal of excess antibody 
 The membrane was washed in 500 ml of buffer 1 containing 0.3 per cent Tween 20 
with vigorous shaking for 15 min.  This step was repeated with fresh buffer 1 
containing 0.3 per cent Tween 20. Membrane was equilibrated in buffer 3 for 5 min.  
2.31.4.9 CSPD incubation 
The membrane in the hybridization bag was incubated at room temperature for 5 min 
and then dried on a filter paper. The membrane was sealed in a hybridization bag or 
between a pair of transparency sheets and incubated at 37°C for 15 min. 
2.31.4.10 Detection of hybridization signal 
 The membrane was placed over an X-ray film in dark and left for 30 min or more. 
Subsequently, the X-ray film was developed by shaking in a developing solution for 2 
to 3 min, washed with distilled water and fixed by shaking in a fixing solution for 2 to 3 
min (or until bands appear).  The processed X-ray film was later washed with tap 
water and dried. 
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2.32 SDS-PAGE 
SDS-PAGE of phage proteins was performed as previously described by Fayerd et 
al., (1993) with some modifications. SDS gel electrophoresis for total protein of 
bacterial cells was performed using the discontinuous buffer system of Laemmli, 
(1970).  The samples were subjected to electrophoreses in 12% or 15% 
polyacrylamide gel at 10-15 mA and stained with commassie brilliant blue R250 
(Fluka).  
2.32.1 Reagents 
TES 
1 ml 10X TE 
4 ml H2O 
5 ml 1M sucrose 
Lysozyme 
50 mg/ml 
Mutanolysin 
5000 U/ml 
Solution A 
29% Polyacrylamide 
1% N,N’-bis-methylene acrylamide 
           Ammonium per sulfate 10% 
           1 M Tris HCl pH (8.8) 
           1.5 M Tris HCl pH (6.8) 
           10% SDS 
           TEMED 
Sample buffer  
0.0625 Tris HCl pH (6.8) 
2% SDS 
10% Glycerol 
5% 2-Mercaptoethanol 
0.001% Bromophenol blue dye 
10X Running buffer (pH 8.3) 
Tris HCl    30.25 g 
Glycine   144.13 g 
SDS    10 g 
  Materials and Methods 
58 
Distilled water  up to 1000 ml 
Destaining Solution 
           Methanol                           300 ml 
 Acetic acid glacial  150 ml 
 Double distilled water 1550 ml 
2.32.2 Procedure 
2.32.2.1 Preparation of phage extracts 
Dialysed phage concentrates were disintegrated by boiling for 10min in sample buffer 
(Laemmli, 1970) 
2.32.2.2 Preparation of cell extracts 
An overnight culture was inoculated into fresh medium and grown to an OD620 of 0.6 
to 0.8 (3-4 h). The cells were collected and weighed. Approximately 250 mg of cells 
were suspended in 100 µl TES with 20 µl lysozyme and 5 µl mutanolysin and 
incubated at 37°C for 30 min. SDS (5-10 µl) was added and the contents were mixed 
until they appeared clear. The contents could be stored at –20°C for 1-2 days. 
2.32.2.3 Preparation of the SDS gel 
The resolving gel (12% or 15%) was prepared by adding the ingredients as follows in 
Table 12 for 50 ml gel: 
Table 12: Preparation of the SDS gel 
Ingredients 12% 15% 
Solution A 20 ml 25 ml 
Distilled water 16.5 ml 11.5 ml 
1.5 M Tris HCl (pH 8.8) 12.5 ml 12.5 ml 
10% SDS 0.5 ml 0.5 ml 
TEMED 20 µl 20 µl 
Ammonium per sulphate 0.5 µl 0.5 µl 
The ingredients were mixed, taking care to avoid bubble formation, and poured into 
the gel assembly quickly. Water was carefully laid on top of the gel and the gel was 
allowed to polymerize for 40 min. The water was later drained before adding the 
sticky gel solution (7%). The 7% gel was prepared as shown in Table 13. 
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Table 13: Preparation of the SDS sticky gel (7%) 
Ingredients Amounts 
Solution A  4.5 ml 
Distilled water  12.5 ml 
1.5 M Tris HCl (pH 8.8)  2.5 ml 
10% SDS  0.2 ml 
TEMED  20 µl 
Ammonium per sulphate (APS)  0.2 µl 
 
The sticky gel solution was poured over the resolving gel as soon as possible and a 
comb was fixed in the sticky gel. The gel was allowed to set and stored refrigerated 
until further use. 
2.32.2.4 Preparation of sample 
Ten microlitres of 4x sample buffer was added to 30 µl of the cell extract and the 
sampls were cooked by placing in boiling water for 4 min. 
2.32.2.5 Running of sample on SDS-PAGE 
After removal of the comb, the wells were filled with 1x running buffer. Samples (up 
to25 µl) were loaded into the wells. Electrophoresis was run at 10 mA until the 
sample entered the resolving zone and then the current was increased to 15 mA. The 
electrophoresis was stopped as soon as the sample front reached the end of the gel. 
2.32.2.6 Staining of the gel 
The gel was carefully removed and stained in Coomassie brilliant blue solution for 5-
6 h. 
2.32.2.7 Destaining of gel 
Excess dye was removed from the gel by repeated washings in destaining solution, 
until clear bands appeared. 
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2.33 Autolysis in buffer system 
Autolysis in buffer system was performed as previously described (NiIskasaari, 
1989; Yokoi et al., 2004). Overnight cultures were inculcated into fresh MRS 
medium and incubated at 37ºC. Bacterial cells were harvested at OD620 1.2 and 
washed once with Ringer’s solution. The cells were resuspended in 10mM Tris pH 7   
and incubated at 37ºC. Lysis was monitored by measuring the OD using Nanocolor 
250 D photometer (Macherey-Nagel, Germany). 
2.34 Prophage curing of L. gasseri BfEL92075  
2.34.1 Induction of strain L. gasseri with MC in the presence of anti-phage 
serum 
Overnight culture from L. gasseri in LMRS broth medium containing 5 % anti-phage 
serum was incubated at 37°C. Five ml  fresh LMRS broth medium containing  5 % 
anti-phage serum were inoculated 1.5% with the overnight culture, incubated at 37°C 
until OD620 0.2-0.3; 5 ml fresh LMRS broth medium containing 5 % anti-phage serum 
and 0.2µg /ml MC were added and the sample was incubated until lysis occurred. 
2.34.2  Selection of the colonies 
From the lysed culture, 30µl were plated onto LMRS agar medium containing 0.1µg 
/ml MC and the plates were incubated anaerobically at 37°C.  25 colonies were 
picked up by teeth picks and streaked in parallel onto LMRS agar and LMRS agar 
containing 0.2µg MC/ml. The plates were anaerobically incubated at 37°C for 72h. All 
the eight colonies grown on the LMRS agar containing 0.2µg MC/ml were inoculated 
into LMRS broth supplemented with 0.2µg MC/ml and after growth regrown in LMRS 
broth overnight at 37°C. 
2.34.3 Re-induction of derivatives 
The eight derivatives of L. gasseri 92075 were induced with 0.2µg MC/ml. 2% 
overnight culture was inoculated into 5 ml LMRS and incubated at 37°C until OD620   
0.2-0.3, then fresh 5 ml LMRS containing MC was added. The final concentration of 
MC was 0.2µg/ml.   
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2.34.4 Spot test  
To confirm the successful prophage-curing a spot test with a phi Lbgas1 lysate was 
performed. MRS was prepared as aforementioned but without autoclaving. The 
medium was instead sterilized by filtration through a 0.45µm filter and kept at 4°C 
until use. Before use, 1% agar was added, and the agar was sterilized by boiling in 
microwave for 3-5 min (Lillehaug, 1997). The ready to use agar contained 10mM 
CaCl2, 1% lactose and 0.2-0.25% glycine. 
Soft agar:  100 ml MRS + 0.3 g agar were sterilized in Microwave oven for 3 min, 
and then CaCl2 and glycine were added to the final concentrations 10mM and 0.2-
0.25 %, respectively.  
Procedure:  
- Overnight cultures (grown anaerobically at 37°C) were diluted in fresh MRS broth 
(10 ml, 1%) and incubated in a water-bath at 37°C until OD620 about 0.5. 
- 0.3 ml of the growing culture,  0.1 ml 40mM CaCl2 , 0.1 ml  7.1% glycine and 0.1 ml 
10% skim milk were mixed with 3 ml soft MRS agar and immediately poured onto 
MRS agar plates.  
- 20µl of serial dilutions of dialyzed phage Lbgas1 lysate (10-1 to 10-7), were spotted 
onto the culture soft agar layer and incubated at 37°C for 24h. 
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3 Chapter I  
 Isolation and Identification of some Lactic acid bacteria by using 
different Molecular biological methods 
3.1 Introduction 
Lactic acid bacteria (LAB) are widely distributed in the nature, occurring naturally as 
indigenous micro-flora in raw milk. LAB are Gram-positive bacteria that play an 
important role in many food and feed fermentations, especially in the production of 
fermented dairy products and many other foods and drinks. LAB used in the dairy 
industry are representatives of the genera Lactobacillus, Lactococcus, Pediococcus 
and Leuconostoc. The lactic acid fermentation, which these bacteria carry out, has 
been known for long and has been applied by humans for making different foodstuffs. 
For many centuries, LAB have served to provide an effective form of natural 
preservation. In addition, they strongly determine flavour, texture and frequently the 
nutritional value of food and feed products (Bettache and Mebrouk, 2004). They 
should possess stable fermentation characteristics and be resistant to 
bacteriophages (Lee, 1996). Lactobacillus is one of the most important genera of 
lactic acid bacteria (LAB), especially because members of this genus play a major 
role in the human and animal gastrointestinal tract, as well as in the production of 
many foods, feeds and beverages (Guarneri et al., 2001). Lactobacilli have a 
worldwide industrial use as starters in the manufacturing of fermented dairy products. 
Moreover, some Lactobacillus strains have probiotic characteristics and are therefore 
included in fresh fermented products or used as encapsulated health products, such 
as freeze-dried powder. The use of some Lactobacillus strains as probiotics is based 
on studies which show, that these species belong to the normal intestinal flora and 
that the strains have beneficial effects on human and animal health (Marteau and 
Rambaud,1993; Salminen, et. al 1996). Probiotics are live microorganisms which, 
when administered in sufficient amounts, award health benefits to the host. Probiotic 
actions, which confer human health benefits (e.g. modulating immune system 
function, reducing host colonization by pathogens and enhancing lactose digestion in 
lactose maldigesters), have been reviewed (Schiffrin and Blum, 2001; Marteau et 
al., 2002). Previous studies have indicated that certain probiotic activities are strain-
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specific (Lee et al., 1993; Gupta et al., 1996; Jacobsen et al., 1999) and thus, 
identification of probiotics to the strain level is essential. This conclusion is supported 
by FAO/WHO guidelines (http://www.fao.org/es/ESN/food/foodandfood_ 
probio_en.stm) for the use of probiotics in food which specify that commercial 
probiotics be identified to the strain level. Further, the ability to identify specific 
probiotic strains provides manufacturers a useful quality control.  Usually, the 
identification of lactobacilli has been based on fermentation of some sugars, 
morphology, and Gram staining, and these methods are still used. However, in recent 
years, taxonomy has changed significantly with the increasing knowledge of the 
genomic structure and phylogenetic relationships between Lactobacillus spp. (Klein 
et al., 1998; Stiles and Holzapfel, 1997; Vandamme et al., 1996). The identification 
of some Lactobacillus species by biochemical methods alone is not reliable 
(Charteris  et al.,1997; Schleifer  et al., 1995). Probiotic health products can 
contain, perhaps due to the lack of good identification methods, Lactobacillus species 
other than those declared on the product specifications. A rapid and reliable species-
specific identification method, e.g., by PCR, is needed. Identification of lactobacilli at 
the strain level is important for their industrial use. Biotechnology industry needs tools 
to monitor, e.g., the use of patented strains or to distinguish proven probiotic strains 
from natural isolates in the host gastrointestinal tract (Soile et al., 1999). Modern 
sensitive and reliabile nucleic-acid-based methods for species-specific detection of 
microorganisms, as 16S and 23S rDNA sequencing, are now routinely used for the 
identification of bacteria (Ludwig and Schleifer, 1994; Stackebrandt and Goebel, 
1994). Genetic differentiation of strains belonging to a number of LAB species such 
as Streptococcus thermophilus (Salzano et al., 1993), Lactobacillus spp. (Dykes 
and von Holy, 1994; Johansson et al., 1995) Enterococcus spp. (Moschetti et al., 
1995), Leuconostoc mesenteroides (Villani et al., 1997) has been effectively 
performed by DNA digestion with restriction enzymes, combined with pulsed-field gel 
electrophoresis (PFGE) or conventional electrophoresis. Molecular typing based on 
polymorphisms of rRNA genes and their intergenic spacer regions and facilitated by 
restriction analysis of these genes after amplification by polymerase chain reaction 
(PCR), has shown prospective as a taxonomic technique, since ribosomal DNA is 
both ubiquitous and highly conserved (Moschetti et al., 1997). Genotypic methods 
used for strain- typing are typically PCR methods e.g., Amplified Ribosomal DNA-
Restriction Analysis (ARDRA) or variations of this method. In PFGE, rare-cutting 
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endonucleases enzymes are used and large genomic fragments are separated 
electrophoretically. PFGE can be used as a primary method for strain differentiation, 
although some probiotic strains from different sources shared highly similar PFGE 
patterns (Yeung et al., 2004). Aims of this study were the isolation and identification 
of some lactic acid bacteria from different sources of Egyptian fermented dairy 
products by using different methods for identification.  In addition, the biodiversity of 
intestinal bacteria of twins babies was determined. These twins were, due to a 
disease of one of them, were fed in different ways. The healthy one was nourished 
with mother breast milk, the other one with formula milk. Influences of the different 
food on the intestinal microflora were analysed.  
3.2 Results and Discussion 
3.2.1 Isolation of lactic acid bacteria 
Lactic acid bacteria were isolated from different Egyptian dairy products as Laban 
rayb, Kariesh and Mish cheese as well as from four faeces samples from twins 
babies at the age of 3 and 4 months. Isolation was performed by standard 
microbiological procedures (see Materials and Methods).  
3.2.2 Identification of bacterial isolates from Egyptian fermented dairy 
products (first part) 
Different identification methods were used to identify the unknown isolates from 
Egyptian fermented dairy products. Only four isolates out of 30 were morphologically 
Lactobacilli as shown by phase contrast microscopy (Fig. 3). For identification of 
these four lactobacilli, biochemical identification, ARDRA, PFGE, cloning and 
sequencing of 16S-23Sr RNA genes were used. Another strategy was performed for 
the identification of the rest of isolates. ARDRA technique was used to divide the 
isolates into groups and at least one isolate from each group was chosen for cloning 
and sequencing of 16S r DAN gene. 
3.2.2.1 Identification of isolates using API 50 CHL system  
Biochemical identification of four isolates from Egyptian cheese was performed with 
an API 50 CHL kit. The identification results given by API 50 CHL system version 5.0 
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database are shown in Table 14. For three isolates (A, C, and E), good identification 
levels were obtained, and identification level of one isolate (D) was regarded as 
acceptable due to different fermentation reactions. Isolates A, C and E were identified 
as Lactobacillus brevis with percentages of identification of 84.5% and the isolate D 
was identified as Lactobacillus plantarum with 91.5%. 
 
Fig. 3: Morphology of four lactobacilli isolates from Egyptian cheese 
Table 14: API 50 CHL Identification of four lactobacilli isolates from 
Egyptian cheese 
Isolate Identification by API 50 CHL (identification comment)a % ID 
A L. brevis (good) 84.5% 
C L. brevis (good) 84.5% 
D L. plantarum (acceptable) 91.5% 
E L. brevis (good) 84.5% 
a Identification by the API 50 CHL kit and the profile status by using the API web software database.   
 
3.2.3 ARDRA-PCR identification: 
Identification of isolates by biochemical identification methods like (API) is for LABs 
with limited value, whereas ARDRA is an efficient identification method 
(Vaneechoutte et al., 1992). ARDRA is a reliable and fast method for routines 
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identification of strain isolates on species level with only minimal instrument 
equipment needs (Hoppe-Seyler et al., 2003). ARDRA was used to differentiate 
species of Lactobacillus. Molecular typing of the rDNA genes and the intergenic 
spacer region can be used as taxonomic marker since ribosomal DNA is ubiquitous 
and contains highly conserved sequences. In this study,  ARDRA was performed for 
four  isolates from Egyptian cheese and some Lactobacillus strains from the 
collection of the institute for microbiology, BfEL (Kiel, Germany), as L. gasseri 
BfEL92075, L. plantarum BfEL 92122, L. rhamnosus BfEL 92149. Also some 
Lactobacillus type and reference strains, as L. plantarum DSM 20174T, L. 
pastorianus DSM 20197, L. johnsonii DSM 20553, L. gasseri DSM 20243, L. zeae 
DSM 20178T, L. reuteri DSM 20016T, L. delb. ssp lactis BfEL 3046/62, L. delb.ssp 
bulgaricus ATCC 12278, L. delb.ssp lactis ATCC 10697 were used for comparison. 
3.2.3.1 DNA preparation  
Fig. 4 shows the electrophoresis analysis chromosomal DNA of the isolates and 
some of Lactobacillus type strains.  
 
Fig. 4: Chromosomal DNA of some Lactobacillus sp and isolates A, C, D 
and E 
 lane 1: L. gasseri BfEL92075; lane 2: L. plantarum BfEL 92122;  lane 3: L. 
rhamnosus BfEL 92149; lane 4: isolate A; lane 5: isolate C; lane 6: isolate D; 
lane 7: isolate E; lane 8:  L. reuteri DSM 20016T; lane 9: L. pastorianus DSM 
20197; lane 10: L. zeae DSM 20178T; lane 11: L. gasseri DSM 20243T; lane 12: 
L. johnsonii DSM 20553; lane 13: L. delb.ssp bulgaricus ATCC 12278; lane14: L. 
delb.ssp lactis ATCC 10697; lane 15: L. plantarum DSM 20174T; lane 16: L. delb. 
ssp lactis BfEL 3046/62 
 
3.2.3.2 Enzymatic amplification of rDNA 
For PCR, universal primers UP68/UP69 (Vaneechoutte et al. 1992) were used to 
amplify a fragment of approx. 2.4 kb, encompassing the 16S, the spacer region and 
part of the 23S rDNA. PCR was carried out in a Eppendorf Mastercycler with an 
annealing temperature at 58ºC (Fig. 5). 
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Fig. 5: PCR amplicons of 16S-23S rRNA genes from Lactobacillus type strains and 
Lactobacillus isolates. 
M: λ StyI; lane 1: L. reuteri DSM 20016T; lane 2: L. pastorianus DSM 20197; lane 3: L. zeae DSM 
20178T; lane 4: L. gasseri DSM 20243; lane 5: L. johnsonii DSM 20553; lane 6: L. delb. ssp 
bulgaricus ATCC 12278; lane 7: L. delb. ssp lactis ATCC 10697;  lane 8: L. gasseri  BfEL 92075; lane 
9: L. plantarum BfEL 92122; lane 10: L. rhamnosus BfEL92149; lane 11: isolate A; lane 12: isolate C;  
lane 13: isolate D; lane 14: isolate E; lane15: blank.  
 
3.2.3.3 Restriction analysis of the 16S-23S rDNA amplicon 
Restriction digests of the 16S-23s rDNA amplicon were carried out with restriction 
enzymes HaeIII and HinfI. Restriction fragment patterns were analyzed by agarose 
gel electrophoresis Fig 6a and b. The restriction patterns of the four isolates A, C, D 
and E and L. plantarum BfEL 92122 were identical to the restriction patterns of type 
strain L. plantarum DSM 20174T. ARDRA also revealed that L. gasseri BfEL 92075 
had the same restriction profile as type strain L. gasseri DSM 20243T. L. rhamnosus  
BfEL 92149 did not correlate with any of the Lactobacillus type and reference strains 
in digests with HaeIII, but showed an identical pattern as type strain L. reuteri DSM 
20016T when digested with HinfI. The restriction profiles of L. delb. ssp. lactis BfEL 
3046 / 62 matched those of L. delb.ssp lactis ATCC 10697T. L. plantarum DSM 
20174T did not match any of the other Lactobacillus type and reference strains. L. 
pastorianus DSM 20197, L. zeae DSM 20178T, L. delb. ssp. bulgaricus ATCC 12278,  
L. delb. ssp. lactis ATCC 10697 also showed species-specific restriction pattern. 
Only the very related strains L. gasseri DSM 2024T and L. johnsonii DSM 20553 
showed identical restriction patterns. In conclusion, ARDRA is an accurate and 
reliable method capable of distinguishing among many of Lactobacillus species 
except for narrow related species L. gasseri and L. johnsonii. 
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(a): Hae III  
 
 (b): Hinf I  
Fig. 6: ARDRA Profiles with Hae III (A) and  Hinf I (B) of some 
Lactobacillus isolates and type strains  .  
M: 100bp Ladder; lane 1: L. plantarum DSM 20174;lane 2: L. plantarum 
BfEL92122; lane 3: isolate A; lane 4: isolate C; lane 5: isolate D; lane 6: 
isolate E; lane 7: L. pastorianus DSM 20197; lane 8: L. zeae DSM 20178;  
lane 9: L. rhamnosus BfEL 92149;  lane 10: L. reuteri DSM 20016; lane 11: 
L. gasseri BfEL 92075; lane 12: L. gasseri DSM 20243; lane 13: L. johnsonii 
DSM 20553; lane 14: L. delb. ssp bulgaricus ATCC 12278; lane15: L. 
delb.ssp lactis BfEL 3046/62; lane 16:  L. delb.ssp lactis ATCC 10697T 
 
3.2.4 Pulsed Field Gel Electrophoresis (PFGE) Genotyping 
PFGE allows clear identification at the strain levels. AscI  and NotI restriction 
fragment patterns of total DNA of Lactobacillus isolates A, C, D and E, identified as 
Lactobacillus plantarum by ARDRA, were compared to those of L. plantarum BfEL 
92122 and type strains L. plantarum DSM 20174T. With AscI (Fig. 7a) we could 
discriminate five different genomic fingerprints for all L. plantarum strains (isolates A, 
C, D, E and L. plantarum BfEL 92122 and type strain L. plantarum DSM 20174T) and 
a completely different genomic fingerprint for L. zeae DSM 20178 T as a negative 
control. The L. plantarum isolate (A) and the type strain L. plantarum DSM 20174T 
had an identical AscI PFGE profiles similar to the L. plantarum BfEL 92122 pattern. 
The genomic fingerprint of L. plantarum isolates C, D and E were very similar except 
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for the differences in fragments between > 48.5 - < 97 kb. We conclude that 
Lactobacillus isolates A, C, D and E were different, but narrowly related strains of L. 
plantarum. 
 
(a) AscI. 
 (b) NotI  
Fig. 7: PFGE profiles of Lactobacillus strains with restriction enzyme AscI (a) and NotI (b). 
 M: low range PFG marker (Biolabs); lane1: L. zeae DSM 20178T; lane 2: L. plantarum BfEL 92122; 
lane 3: L. plantarum DSM 20174T; lane 4: Isolate A;   lane 5: Isolate C; lane 6: Isolate D; lane 7: 
Isolate E 
3.2.5 Cloning and sequencing of 16S-23S rRNA genes 
The determination of 16S and 23S rRNA gene sequences is considered as one of 
the bases of modern microbial taxonomy. For confirmation of the previous 
identification of lactobacilli isolates, PCR products of the16S-23S rRNA genes were 
amplified using universal primers UP68 and UP69 and cloned into pEGM-T-easy 
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vector and transformed into E. coli JM109. Proper transformants were selected by 
blue/white colony screening.  Plasmid DNA of transformants were isolated and 
analysed by agarose gel electrophoresis (Fig. 8). 
 
Fig. 8: Clones of 16S-23SDNA fragment of   some Lactobacillus isolates 
(C): PGEM-T-easy vector; clones 1: L.  plantarum BfEL 92122;   clones 2: L. zeae DSM 20178; 
clones 3: L. rhamnosus BfEL 92149;  clones 4: L. plantarum DSM 20174T;  clones 5: Isolate A; 
clones 6 : Isolate C ; clones 7 : Isolate D;  clones 8 : Isolate E. 
 
One plasmid from each group was sequenced, with T7 and SP6 promoters primers. 
The sequences were searched at National Center for Biotechnology Information 
(NCBI, Bethesda, MD, USA) for similarities in the Gen-Bank database. The obtained 
data after BLAST analysis revealed that the similarities of isolates A, C, D and E with 
L. plantarum were 88%, 99%, 96% and 96%, respectively. L. plantarum BfEL 92122 
and L. rhamnosus BfEL 92149 had similarities with L. plantarum (98%) and L. casei 
(96%), respectively. L. plantarum DSM 20174T and L. zeae DSM 20178 matched with 
L. plantarum (98%) and L. casei (97%), respectively. 
3.3 Identification of bacterial isolates from Egyptian fermented dairy products 
(second part of isolates) 
Another strategy was performed for identification of the rest of isolates (46 isolates), 
ARDRA technique was used to divide the isolates into groups, within the same 
restriction profile. At least one isolate from each group was chosen for cloning and 
sequencing of 16S r DNA gene. 
3.3.1 PCR of 16S-23S rDNA 
For PCR, universal primers UP68/UP69 (Vaneechoutte et al. 1992) were used to 
amplify the fragment (approx. 2.4 kb) encompassing the 16S rDNA, the spacer region 
and part of the 23S rDNA. PCR was carried out in a Gene-Amp-system with an 
annealing temperature at 58ºC. The obtained amplicons of approx. 2.4 kb are shown 
in Fig. 9 and 10. 
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Fig. 9: PCR amplicons of 16S-23S rRNA genes from bacterial isolates numbers 1-28. 
M: λStyI, lanes 1-12: Kariesh cheese isolates, lanes 13-14 and 15-25: Laban rayeb  isolates 
lanes 26&27:  Mish cheese isolates 
 
 
Fig. 10: PCR amplicons of 16S-23S rRNA genes from bacterial isolates numbers 28-46. 
M: λStyI, lanes 28-36: Kariesh cheese isolates, lanes 36-46: Laban Rayeb isolates.  
 
3.3.2 ARDRA using enzymes HaeIII & HinfI 
Restriction digests of the 16S -23s rDNA amplicons were carried out with the 
restriction enzyme HaeIII (Fig. 11) and HinfI (Fig. 12). Restriction fragment patterns 
were analyzed by agarose gel electrophoresis. The ARDRA technique with HaeIII 
and HinfI divided the isolates into some clusters, summarized in Table 2. At least one 
isolate from each group was chosen for accurate identification by sequencing 16S or 
16S-23S rRNA genes. 
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Fig. 11: HaeIII restriction patterns of 16S-23Sr RNA of isolates numbers 1-46. 
M: 100bp ladder; lanes 1-12: Kariesh cheese; lanes 13-14 and 15-25: Rayeb milk lanes 26&27: Mish 
cheese; lanes 28-36: Kariesh cheese isolates; lane 36-46: Laban Rayeb isolates. 
 
 
 
 
Fig. 12: HinfI restriction patterns of 16S-23SrRNA of isolates numbers 1-46. 
M: 100bp ladder; 1-12: Kariesh cheese; lanes 13-14 and 15-25: Laban Rayeb; lanes 26&27: Mish 
cheese; lanes 28-36: Kariesh cheese isolates; lanes 36-46: Laban Rayeb isolates.   
 
The restriction profiles of isolates 1- 27 (Fig 11 and 12) were identical for isolates 1, 3 
and 5 and for isolates 2, 4, 7, 8, 9 and 10, while they similar for isolates 12 and 13. 
Isolates 15, 16,and 17, as well as the group of isolates 19, 20, 21, 22, 22, 23, 24 and 
25 showed  identical profiles, isolates 26 and 27 had a similar profile. The restriction 
profiles of isolates 6, 11, 14, 18 were unique and did not match to any of other 
profiles (Table 2). From these groups, 10 isolates (1, 2, 6, 11, 12, 14, 15, 18, 19, and 
26) were chosen for accurate identification. PCR applied with primers UP68 and 
UP69 to amplify a fragment (approx. 2.4 kb) encompassing the 16S, the spacer 
region and part of the 23S rDNA, Fig. 13.  
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The restriction profiles of isolates 28- 46 (Fig. 11 and 12) revealed  two groups: the 
first group  contained isolates 28, 31, 32, 33, 37, 38; the second one included 
isolates 29, 39, 40, 41, 42, 43, 44, 45, 46. The restriction profiles also disclosed that 
isolate number 30 and isolate number 35 had unique profile. At least one isolate from 
each group was chosen for cloning and sequencing of a part of 16S r RNA gene 
(isolates 29, 30, 32, 35, 39, and 40), Fig. 14.   
 
Fig. 13: PCR amplicons of 16S-23S r RNA genes from selected 
isolates between numbers 1-27.   
M: λStyI; lane 1:  isolate 1; lane 2: isolate 2; lane 3 isolate6; lane 4:  
isolate 11; lane 5: isolate 12; lane 6: isolate 14; lane 7:  isolate15; lane 8: 
isolate 18; lane 9: isolate 19; lane10: isolate 26. 
 
 
Fig. 14: PCR amplicons of 16S r RNA gene from selected isolates 
between numbers 28-46.   
M: λStyI; lane 1 : isolate 29; lane 2: isolate 30; lane 3:  isolate 32; lane 4: 
isolate 35; lane 5: isolate 39; lane 6: isolate 40. 
 
3.3.3 Cloning and sequencing of 16S-23S or 16S rRNA genes 
Universal primers  UP68/UP69 were used for amplification of 16S - 23S rRNA genes 
isolates 1, 2, 6, 11, 12, 14, 15, 18, 19 and 26 and universal primers  16SF/DG74 for 
the 6 isolates 29, 30, 32, 35, 39 and 40. PCR-fragments were cloned into pSt Blue I 
vector (Novagen) or pDrive vector (Qiagen) and transformed into E. coli (Nova Blue) 
competent cells. Proper transformants were selected by blue/white colony screening 
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and subjected to sequencing of the cloned fragments. The data in Table 15 
summerize the result of identification after searching the sequences at the National 
Center for Biotechnology Information (NCBI, Bethesda, MD, USA) for similarity in the 
Gen-Bank database. The obtained data after BLAST analysis revealed similarities of 
99%.  
Table 15: List of identified isolates 
Group 
Isolates numbers with identical 
restriction profiles 
Identification 
1 1 = 3 = 5 Lactobacillus  fermentum IS1 
2 2 = 4 = 7 = 8 =9 = 10 Lactobacillus plantarum IS2 
3 12 = 13 Lactococcus  lactis IS5 
 14 Streptococcus thermophilus IS6 
4 15 = 16 = 17 Lactococcus  lactis IS7 
 19 = 20 = 21 = 22 = 22 = 23 = 24 = 25 Lactococcus  lactis IS8 
5 26 = 27 Lactococcus  lactis IS9 
6 28 = 31 = 32 = 33 = 37= 38 Lactobacillus plantarum IS13 
7 
29 = 39 = 40 = 41 = 42 = 43 = 44 = 45 
= 46 
Lactobacillus fermentum IS11 
Lactobacillus fermentum IS15 
Lactobacillus fermentum IS16 
8 6 --NI-- 
9 11 --NI-- 
10 18 Enterococcus saccharinimus IS8 
11 30 Lactobacillus fermentum IS12 
12 35 Leuconostoc mesenteroides IS14 
= identical      ---NI--- Not Identified,    Strains marked bold were used for sequencing. 
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3.4 Detection and comparison of the biodiversity of intestine bacteria from 
feces of twin babies  
For the differentiation of the unknown isolates from feces of twin babies in the 
available work the molecular-biological methods PCR and ARDRA were used. 
Isolates of the baby nourished with mother's milk were named with the letter A, and 
the letter B was used for isolated from the twin, which was due to a disease, 
nourished with bottle formula. Numbers 1-20 were used to label isolates taken at the 
age of three months and numbers 21-40 for those collected from feces at the age of 
four months.  
3.4.1 Identification of isolates of intestine bacteria from babies’ feces by PCR 
with genus specific primers 
For identification of the unknown isolates from babies feces on genus level, genus- 
specific primers lm26/lm3, for Bifidobacterium, LactoF/LactoR for Lactobacillus as 
well as, primers St1/St2 for S. thermophilus were used. Moreover, PCR with the 
universal primers UP68/UP69 for 16S-23S rDNA and primers DG74/16SF for 16S 
rDNA were also applied.  
3.4.1.1 PCR for the isolates from feces of babies with genus specific primers 
Amplification of the 16S rDNA with the Bifidobacterium specific primer-pair lm26 and 
lm3 (Kaufmann et. al 1997) resulted in five positive isolates. These positive isolates 
were named 12A, 12B, 16A, 17A and 19A all with a fragment size of 1417 bp (data 
not shown). Primers LactoF and LactoR (Roy et. al 2004) were used to investigate 
the remaining 75 unknown Isolates. PCR resulted in amplicons with a fragment size 
of approx. 230 bp for all used isolates, including negative controls of 17A and S. 
thermophilus as showed in Fig. 15.  
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Fig. 15: PCR of the babies Feces isolates with the Lactobacillus specific Primers LactoF 
and LactoR. 
M: 100bp-Ladder; lanes 1-13: isolates 1A-13A; lane14: L. gasseri (DSM 20243
T
); lanes15 & 
16: St. thermophilus; lane17: B. breve17A; lane 18: Blank. 
A change of the annealing temperature did not improve the specifity of the primer 
pair. Therefore, a primer combination consisting of primer LactoF as forward primers 
and the Lactobacillus specific reverse primer LbLMA1 (Dubernet et. al 2002) were 
used, resulting in PCR products with sizes of approx.1600 bp. (Fig. 16). However, the 
negative controls 17A and two S. thermophilus isolates also resulted in a clear signal 
of appropriate size. An increase of the annealing temperature by 2 °C improved the 
specificity of the PCR. Even at the improved conditions the negative control 17A still 
showed a weak signal of comparable size (Fig. 18). All reference strains except DSM 
20197, as well as the isolates 1-2A, 4-6A, 8-10A, 13-14A, 22-23A, 26A and 36A 
revealed strong PCR signals. Amplification with isolates 3A, 7A, 11A, 15A, 20A, 24-
25A, 27-28A and 37A as well as 1B, 18-20B and 30B led to weak signals of 
appropriate size. All other isolates were negative. The experiments with primers 
LactoF and LbLMA1 are presented in Fig. 16, 17, 18 and 19a and b.  
 
Fig. 16: PCR of Lactobacillus reference strains with the primers   LactoF/LbLMA1. 
M: λStyI; lane 1: L. reuteri (DSM 20016
T
); lane 2: L. pastorianus (DSM 20197); lane 3: L. 
zeae (DSM 20178); lane 4: L. gasseri (DSM 20243
T
); lanes 5&8: L. delbrueckii ssp. lactis 
(DSM 20072, ATCC 10697); lane 6: L. johnsonii (DSM  20553); lane 7: L. bulgaricus 
(ATCC 12278); lane 9: L. plantarum ssp. plantarum (DSM 20174
T
); lane 10: blank 
sample. 
 
Fig. 17: PCR of babies’ feces isolates with Lactobacillus specific primers LactoF and 
LbLMA1. 
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M: λ StyI; lanes 1-11: isolates 1A-11A; lanes 12-14: isolates 13A-15A; lane 15: isolate 
18A; lanes 16-23: isolates 20A-27A. 
 
Fig. 18: PCR of babies’ feces isolates (28-40A with 
Lactobacillus specific primers LactoF and LbLMA1. 
M: λ StyI; lanes 1-13: isolates 28A-40A; lane14 L. gasseri (DSM 
20243T); lanes 15&16: St. thermophilus; lane 17: B. breve (17A). 
 
Fig. 19: PCR of babies’ feces isolates (1-20B) with Lactobacillus specific primers LactoF 
and LbLMA1 
M: λ StyI; lanes 1-11: isolates 1B-11A; lane 12: isolate 13B; lanes 13-19: isolates 14B-20B; lane 
20: L. gasseri (DSM 20243T); lane 21: B. breve (17A); lanes 22&23: St. thermophilus 
 
 
Fig. 20: PCR of babies’ feces isolates (21-40B) with Lactobacillus specific primers LactoF 
and LbLMA1 
M: λ StyI; lanes 1-12: isolates 21B-33A; lanes 13-19: isolate 34B-40B; lane 20: L. gasseri 
(DSM 20243T); lanes 21&22: St. thermophilus lane 23: B. breve (17A). 
 
To investigate the presence of Streptococcus in the feces micro-flora the S. 
thermophilus specific primers St1 and St2 were used. None of tested isolates 
revealed positive signals (data not shown).   
The identification of Lactobacillus on genus level was more difficult compared to the 
Bifidobacteria, since primers LactoF and LbLMA1 appeared to be less specific. 
 
3.4.1.2 PCR with isolates from babies’ feces using universal primers 
All isolates, except 12A, 12B, 16A, 17A, and 19A were subjected to PCR with 
universal primers UP68/UP69. All samples yielded positive signals. Amplicons of 
approx. 2400 bp in size including 16S r RNA gene, intergenic spacer region and a 
part of 23S r RNA gene were obtained (Vaneechout et al., 2002). PCR with the 
universal primer DG74 and 16SF was performed to amplify the 16S r RNA genes for 
sequencing. All isolates revealed positive signals with an amplicon size of 1536 bp. 
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3.4.2 Differentiation of babies’ feces isolates by ARDRA  
3.4.2.1 ARDRA of Lactobacillus Isolates from babies’ feces 
PCR products obtained with primers LactoF and LbLM1were not suitable for ARDRA. 
Therefore amplicons of 16S r RNA gene, intergenic spacer region and a part of 23S r 
RNA gene with size approx. 2400 bp, obtained with universal primers UP68/UP69 
were used for ARDRA. Restriction analysis with enzymes HaeIII, HhaI, HinfI and TaqI 
was applied.  Restriction-digests with HhaI showed two different patterns. The 
restriction profiles of isolates 1-2A, 4-6A, 8A, 13A, 14A, 22-23A, 26A and 36A were 
identical to the restriction profile of the reference strain L. zeae (DSM 20178T). None 
of the reference strains matched with isolates 9A and 10A. Digest with HinfI achieved 
three different restriction profiles. Isolates 9A and 13A had identical patterns, which 
were similar to the pattern of L. gasseri (DSM 20243T) as well as L. johnsonii (DSM Z 
20553). The restriction profile of the isolate 10A did not match with any of reference 
strains. The remaining isolates matched with L. zeae (DSM Z 20178T).  ARDRA 
restriction profile of with TaqI were identical to the reference strain L. zeae, DSM 
20016T indicating that all these isolates are closely related to this bacterial species. 
Isolate 9A did not match with the restriction profiles of any of the reference strains. 
9A, 10A and 13A could not be differentiated unambiguously by ARDRA. 
3.4.2.2 Allocation of the isolates from babies’ feces by ARDRA  
With exception of the isolates identified as Bifidobacterium no further isolates 
identified by PCR as Lactobacillus could be differentiated clearly according the past 
criteria, Therefore ARDRA with TaqI was performed for 75 isolates. For isolates from 
baby A (Fig. 21, 21 and 23) two, and for the isolates from baby B (Fig. 24 and 25) 
three different restriction profiles were found.  
 
Fig. 21: ARDRA (Primer UP68/UP69) with TaqI for some isolates from 
baby’s (A) feces.  
M: 100bp-Ladder; lane 1: isolate 1A; lane 2: isolate 2A; lane 3: isolate 4A; 
lane 4: isolate A5; lane 5: isolate A6; lane 6: isolate A8; lane 7: isolate A9; 
lane 8: isolate 10A; lane 9: isolate 13A; lane 10: isolate 14A; lane 11: 
isolate 22A; lane 12: isolate 23A; lane13: isolate 26A; lane 14: isolate 36A. 
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Fig. 22: ARDRA (Primer UP68/UP69) with TaqI enzyme of some 
isolates from babies feces. 
M: 100bp-Ladder; lane 1: isolate 3A;  lane 2: isolate 11A; lane 3: 
isolate 15A; lane 4: isolate 18A; lane 5: isolate 20A; lane 6: isolate 
24A; lane 7: isolate 31A; lane 8: isolate 32A 
 
Fig. 23: ARDRA (Primer UP68/UP69) with TaqI enzyme of some 
isolates from babies feces. 
M: 100bp-Ladder; lane 1: isolate 7A; lane 2: isolate 21A; lane 3: isolate 
25A; lanes 4-7: isolates 27A-30A; lanes 8-10: isolates 33A-35A; lanes 
11-14: isolates 37A-40A. 
 
 
Fig. 24: ARDRA (Primer UP68/UP69) with TaqI enzyme of 
some isolates (B) from babies feces. 
M: 100bp-Ladder; lane 1: isolate 1B;  lane 2: isolate 9B; lane 3: 
isolate 18B; lane 4: isolates 19B; lane 5: isolates 20B; lane 6: 
isolate 21B; lane 7: isolates 22B; lane 8: isolates 23B 
 
 
Fig. 25: ARDRA (Primer UP68/UP69) with TaqI enzyme of some isolates (B) from babies feces. 
M: 100bp-Ladder; lanes 1-7: isolates 2B-8B; lane 8: isolate 10B; lane 9: isolate 11B; lanes 10-14: 
isolates 13B-17B; lanes 15-31: isolates 24B-40B. 
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ARDRA with TaqI allowed dividing the 75 isolates into three groups. 
Group 1: 1-8A, 10A, 13-15A, 18A, 20-32A, 34-40A; 1-2B, 6B, 9-10B, 14-15B, 20-
22B, 24-25B, 28B, 30B, 32B, 37-38B, 40B   
Group 2: 9A, 11A, 33A; 4B, 7B, 18B, 29B.  
Group: 3B, 5B, 8B, 11B, 13B, 16-17B, 19B, 23B, 26-27B, 31B, 33-36B, 39B.  
3.4.2.3 Sequencing of selected isolates 
For identification, sequencing of the 16S rDNA of the following selected isolates 1A, 
2A, 10A, 13A and 15A from group 1, 9A and 11A from group 2 and 13B, 19B and 
33B from Group 3 were performed. PCR amplicons of the 16S rDNA amplified with 
primers DG74 and 16SF rDNA were cloned in the vector pStBlue-1 and approx. 1000 
bp from the 1536 bp fragment was sequenced. The receiving data were compared 
with those in data bases summarized 16S rDNA sequences. The isolates 2A, 10A, 
13A, 15A from the group 1 and the isolate 11A from group 2 were identified as L. 
rhamnosus. The isolates 1A (group1) and 9A (group 2) identified as L. paracasei. 
13B, 19B and 33B (from group 3) were identified as Enterococcus gallinarum and 
Enterococcus saccharolyticus, respectively (Table 16). 
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Table 16: Summery of identified isolates from babies’ feces. 
Isolate Identification 
1A  Lactobacillus paracasei ISO1 
2A Lactobacillus rhamnosus ISO2 
9A Lactobacillus paracasei ISO3 
10A Lactobacillus rhamnosus ISO4 
11A Lactobacillus rhamnosus ISO5 
13A Lactobacillus rhamnosus ISO6 
15A Lactobacillus rhamnosus ISO7 
13B Enterococcus gallinarum ISA1 
19B Enterococcus saccharolyticus ISA2 
33B Enterococcus saccharolyticus ISA3 
 
Significant differences in the microflora of the two babies may be due to the nutrition. 
Only Lactobacilli were isolated from the infant A, who was feeded with breast milk 
and several Enterococcus sp. from infant B, who was feeded with Milk formula. 
These results may demonstrate that human milk is considered to be an important 
factor affecting infants gut microflora composition and breast feeding can be a 
significant source of Lactobacilli in the infant gut (Martin et. al.;2005).   
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4 Chapter II 
 Phenotypic characterization of some Lactobacilli  
 
4.1 Introduction 
 
Products available on the market that contain probiotics are one reason for the 
increases consumption of fermented milk. (Chumchalova et al., 2004). Probiotics 
are defined to be live microorganisms, which exert a positive effect on the health and 
the well-being of the host (Ouwehand and Salminen, 1998 and Klingberg et al., 
2005). Probiotic bacteria should survive passage through the upper part of the 
gastrointestinal tract. High tolerances to low pH and bile salts concentrations 
corresponding to the conditions of the human gastrointestinal tract (GIT) have 
therefore been considered as important selection criteria (Tuomola et al., 2001; 
Klingberg et al., 2005). Probiotic bacteria are exposed to acid-stress in the stomach 
with its low pH (pH3.5 or lower) (Barada, 1991). Before passing to intestinal tract, 
they must therefore survive transit through the stomach (Dunne et al., 2001; Martin 
et al., 2005. In the present study we considered survival at pH 3.5 as a criterion for 
acid tolerance, although acid tolerance until up to pH 2 was tested to detect highly 
acid tolerant strains. Acid tolerance was evaluated by growing strains in MRS broth 
adjusted to acidic pH 3.5 and 2 and non-acidified MRS broth pH 6.5 at 37ºC for 90 
min, since the food transit time through the human stomach is about 90 min (Barada, 
1991; Chou and Weimer, 1999). 
Bile tolerance, another important criterion for selection of probiotic strains, enables 
them to survive, grow and exert their actions in the small intestine. Strains that are 
able to grow and metabolize in the presence of physiological levels of bile salts 
should logically be more likely to survive intestine transit. Although the degree of bile 
tolerance required for maximum growth of the microorganisms in the intestine tract is 
unknown, it is important to select those strains having a high degree of bile salt 
tolerance.  
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Concentration of 0.3% oxgall closely approximates the bile levels found in the 
gastrointestinal tract (Gilliland et al., 1984; Goldin and Gorbach, 1992; McAuliffe 
et al., 2005). 
Also, antimicrobial activity against pathogenic bacteria is considered as one of the 
important criteria for the selection of probiotic strains. Lactic acid bacteria produce 
various antimicrobial compounds such as organic acids and their derivatives (phenyl 
lactic acid and 4-hydroxyl-phenyl-lactic acid ,  Lavermicocca et al., 2000) , diacetyl, 
hydrogen peroxide, and bacteriocins or bacteriocidal proteins during lactic 
fermentation (Anderssen et al.,1998; Sholeva et al., 1998; Ouwehand, 1998; 
Zhennai, 2000; Oyetayo et al., 2003; Savadogo et al., 2004). 
Lactobacilli strains, are frequently used for production of fermented milks with 
enhanced probiotic effect, may provide strong antagonistic effect towards Gram- 
negative bacteria, Gram-positive bacteria and fungi (Suskovic et al., 1997a,b). 
Lactobacillus species are considered as part of the normal microflora of the 
gastrointestinal and female genital tract (Avlami et al., 2001). Lactobacilli are widely 
used as probiotics or in starter cultures. They have the potential to serve as hosts of 
antibiotic resistance genes with the risk of transferring the genes in other lactic acid 
bacteria and/or pathogenic bacteria. In recent years, studies on the selection for and 
the dissemination of antibiotic resistances have focused on clinically relevant 
bacterial species. Recently, it was speculated that food bacteria may also act as 
reservoirs of antibiotic resistance genes (Hummel et al., 2007; Mathur and Singh, 
2005).  
There is little information regarding presence of antibiotic resistance genes in starter 
strains and their potential to transfer the resistance genes to pathogens (Mathur and 
Singh, 2005). Reduced susceptibility to certain antibiotics is not an unusual feature 
of food isolated microorganisms including starter and probiotic cultures.  Many of 
these resistances are due to complex intrinsic features such as cell wall structure or 
metabolic properties (Kastner et al., 2006). The antibiotic susceptibility of 
Lactobacillus species has received little attention (Charteris et al., 1998) in this 
regard; antibiotic susceptibility testing of lactic acid bacteria may be advisable in a 
number of instances e.g. for checking the biosafety of potentially probiotic isolates 
and genetically modified strains used in biotechnology (Huys et al., 2002).  
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The objectives of the present study were the evaluation and characterization of the 
Lactobacillus strains, which identified in the previous chapter (11 from Egyptian 
fermented dairy products, 7 from baby’s faeces in addition to, 9 from BfEL culture 
collection) and from   through probiotic selection criteria (acid tolerance, bile salts 
resistance and antimicrobial activity). Also, a safety assessment of some 
Lactobacillus isolates was done. To achieve that, we studied susceptibility of 26 
Lactobacillus to 13 antibiotics including inhibitors of cell wall synthesis, protein 
synthesis and nucleic acid synthesis. 
 
4.2 Results and discussion 
4.2.1 Acid tolerance 
Twenty-two strains were tested for tolerance to low pH for up to 90 min (Fig 26). 
According to Lan-szu and Bart, (1999), strains that showed little or no reduction in 
colony-forming units per millilitre of culture were considered to be candidates for 
selection of acid-tolerant strains. Nearly all strains investigated survived very well 90 
min incubation at pH 3.5 (Figs. 26-(1-22). These results are in agreement with those 
of other authors (Chou and Weimer 1999; Xanthopoulos et al 2000 and Lin and 
Chin 2000). At pH 2 significant differences in acid resistance were observed between 
different strains. CFUs of Lactobacillus fermentum IS12, L. rhamnosus ISO7 and L. 
johnsonii BfEL92170 decreased only one logarithmic unit after 90 min at pH 2, those 
of L. fermentum IS16 and L. brevis BfEL 92027 by two logarithmic units. The cell 
number of strains L. fermentum IS11, L. fermentum IS15, L. rhamnosus ISO4, L. 
rhamnosus ISO5 and L. amylovorus BfEL 92203 were reduced by three log units, 
those of L. fermentum IS1, L. plantarum IS2 and L. fermentum IS16 by four and 
those of L. rhamnosus ISO2, L. paracasei ISO3, L. rhamnosus ISO6 and L. gasseri 
BfEL92075 by five logarithmic units. L. plantarum IS13, L. paracasei ISO1, L. 
plantarum BfEL 92122 and L. acidophilus BfEL92015 did not survive at pH2 for 90 
min. These results are in conform with those represented by Lin and Chin 2000, that 
most of Lactobacillus acidophilus strains did not survive at pH 2. 
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 Fig. 26: Survival of Lactobacillus ssp. (log10 cfu/ml) in MRS medium at different 
pH values during incubation at 37 °C for 90 min. 
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Fig. 26: continued  
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L. acidophilus BfEL 92015
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Fig. 26: continued  
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L. brevis BfEL 92026
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L. amylovorus BfEL 92203
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4.2.2 Bile tolerance 
Data in Figs. 27-(1-27) show the growth abilities of twenty-seven Lactobacillus strains 
in the presence of different concentrations (0.1; 0.3; 0.5; 1 and 3%) of ox-gall bile 
salts. Most strains grew in the presence of 0.1% bile salts except L. casei BfEL 
92040, L. paracasei ISO1 and L. rhamnosus ISO6, which did not grow at any of the 
bile salt concentrations tested. Most of the strains grow well in to 0.3% bile salts, 
except L. gasseri BfEL 92075, L. plantarum (A), L. plantarum (C), L. plantarum (D) L. 
plantarum (E), and L. rhamnosus ISO2. L. plantarum BfEL 92122, L. fermentum 
IS12, L. fermentum IS15, L. fermentum IS16, L. plantarum IS2, L. plantarum IS13. L. 
paracasei ISO3, L. rhamnosus ISO4, L. rhamnosus ISO5 and L. rhamnosus  ISO7 
showed growth up to 0.5% ox–gall bile salts (Figs. 27-(2, 12, 13,14,15,16, 23, 24, 25 
Fig. 26: continued  
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and 27), respectively. Only L. plantarum BfEL 92122 was highly resistant to bile salts 
and able to grow in 3% bile (Fig. 27-2).  
Most of Lactobacillus strains tested for bile salts hydrolase activity expressed bile 
salts hydrolase and deconjugated taurine or glycine-bile acid or both of them and 
produced a precipitate around the colonies on agar medium which containing 0.5% 
TDCA or 0.5% GDCA (Table 17 and Fig. 28).  
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Fig. 27: Effect of different concentratons of ox-gall bile salts on growth of 
lactobacili  
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Fig. 27: Continued  
  Chapter II 
92 
 L. plantarum A 
Time / H
0 2 4 6
O
.
D 
(62
0n
m
)
0,01
0,1
1
10
  0 % 
 0.1% 
 0.3% 
 0.5% 
        (17) 
 L. plantarum C
Time / H
0 1 2 3 4 5 6 7
O
.
D 
(62
0n
m
)
0,01
0,1
1
10
  0 % 
 0.1% 
 0.3% 
 0.5% 
      (18) 
 L. plantarum D
Time / H
0 1 2 3 4 5 6 7
O
.
D 
(62
0n
m
)
0,01
0,1
1
10
  0 % 
 0.1% 
 0.3% 
 0.5% 
                                            (19) 
 L. plantarum E
Time / H
0 1 2 3 4 5 6 7
O
.
D 
(62
0n
m
)
0,01
0,1
1
10
  0 % 
 0.1% 
 0.3% 
 0.5% 
                                            (20) 
L. paracasei ISO1
Time / H
0 2 4 6 8 10 12
O
.
D 
(62
0n
m
)
0,01
0,1
1
10
 0 % 
0.1% 
0.3% 
 0.5% 
                                (21) 
L. rhamnosus ISO2
Time / H
0 2 4 6 8 10 12
O
.
D 
(62
0n
m
)
0,01
0,1
1
10
  0 % 
 0.1% 
 0.3% 
 0.5% 
        (22) 
Fig. 27: Continued  
  Chapter II 
93 
 L. paracasei ISO3
Time / H
0 2 4 6 8 10 12
O
.
D 
(62
0n
m
)
0,01
0,1
1
10
  0 % 
 0.1% 
 0.3% 
 0.,5% 
       (23) 
L. rhamnosus ISO4
Time / H
0 2 4 6 8 10 12
O
.
D 
(62
0n
m
)
0,01
0,1
1
10
 0 % 
 0.1% 
 0.3% 
 0.5% 
        (24) 
 L. rhamnosus ISO5
Time / H
0 2 4 6 8 10 12
O
.
D 
(62
0n
m
)
0,01
0,1
1
10
  0 % 
0.1% 
 0.3% 
 0.5% 
                                             (25) 
L. rhamnosus ISO6
Time / H
0 2 4 6 8 10 12
O
.
D 
(62
0n
m
)
0,01
0,1
1
10
 0 % 
0.1% 
 0.3% 
 0.5% 
                                             (26) 
L. rhamnosus ISO7
Time / H
0 2 4 6 8 10 12
O
.
D 
(62
0n
m
)
0,01
0,1
1
10
  0 % 
 0.1% 
 0.3% 
 0.5% 
 
     (27) 
 
 
 
Fig. 27: Continued  
  Chapter II 
94 
Table 17: Bile salts hydrolase activity of various Lactobacillus strains 
 
Strains 
Bile salts hydrolase activity 
against TDCA GDCA 
Lactobacillus plantarum BfEL92122 + + 
Lactobacillus  brevis BfEL 92026 + + 
Lactobacillus rhamnosus BfEL92149 + + 
Lactobacillus gasseri BfEL 92075 
- + 
Lactobacillus plantarum (A) 
- + 
Lactobacillus plantarum (C) 
- + 
Lactobacillus plantarum (D) 
- + 
Lactobacillus plantarum (E) 
- + 
Lactobacillus acidophilus BfEL92015 + + 
Lactobacillus johnsonii BfEL 92170 + + 
Lactobacillus amylovorus BfEL92203 + - 
Lactobacillus casei BfEL92040 
- + 
Lactobacillus fermentum IS1 
- - 
Lactobacillus plantarum IS2 
- 
- 
 Lactobacillus fermentum IS11 
- - 
Lactobacillus fermentum IS12 
- - 
Lactobacillus plantarum IS13 
- - 
Lactobacillus fermentum IS15 
- - 
Lactobacillus fermentum IS16 
- - 
Lactobacillus paracasei ISO1 
- - 
Lactobacillus rhamnosus ISO 2 
- - 
Lactobacillus paracasei ISO3 + - 
Lactobacillus rhamnosus ISO 4 + - 
Lactobacillus rhamnosus ISO 5 
- - 
Lactobacillus rhamnosus ISO 6 
- - 
Lactobacillus rhamnosus ISO 7 + + 
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     A                         B              C  
Fig. 28: Bile salt hydrolase activity as detected by plate assay method on MRS supplemented 
with TDCA or GDCA. 
(A): MRS; (B): MRS+0.5% TDCA; (C): MRS+0.5%GDCA; 1: L. plantarum  
BfEL 92122; 2: L. brevis  BfEL 92026; 3: L. rahmnosus BfEL 92149;  4:  L. 
gasseri  BfEL 92075; 5: L. plantarum  (A);  6: L. plantarum  (C); 7: L. 
plantarum  (D); 8: L. plantarum  (E); 9: L. acidophilus BfEL 92015; 10: L. 
johnsonii BfEL 92170; 11: L. amylovorus BfEL 92203; 12: L. casei  BfEL 
92040. 
 
 
4.2.3 Antimicrobial activity  
Antimicrobial activity screening of 26 lactobacilli strains isolated from traditional 
Egyptian dairy products, from babies faeces and from the culture collection BfEL–
KIEL (see Table 18) against different pathogenic bacteria as indicators was 
performed. Antimicrobial activities were determined in agar diffusion tests using 
overnight cultures of the test bacteria and spent media of these cultures at their 
original pH-values and after adjusting the pH to 7. Inhibition was observed with viable 
cells only but not with spent media, independently of the pH-value (Fig. 29). 
However, antimicrobial activities were detected in the growth media after changing 
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the growth conditions. Lactobacilli cultures were grown anaerobically for about 7 
hours (O.D. 0.5-1), then 0.5% of each culture were transferred immediately under 
aseptic conditions to warmed MRS broth medium and allowed to grow aerobically 
with slight shaking. These growth conditions were selected to expose the growing 
cells to stress. The results shown in Table 18 and Fig. 29 indicate that most of the 
Lactobacillus strains produced antimicrobial substances against some pathogens. 
Staphylococcus aureus BfEL 91161 and Staphylococcus epidermis BfEL 91112, 
were inhibited by the most of Lactobacillus strains, which agrees to observations 
represented by Gulahmadov et al., 2006; Olivares et al., 2006. L. gasseri BfEL 
92075, L. brevis BfEL92026, L. plantarum BfEL92122, L. plantarum (A, D, E) and L. 
casei BfEL92040 showed, in addition, slight inhibitory effects against Enterococcus 
faecalis BfEL90519 and Listeria monocytogenes. The screening also revealed that L. 
fermentum IS1 inhibited Enterobacter aerogenes BfEL 9805, Serratia marcescens 
BfEL 98027, S. aureus BfEL 91161, S. epidermidis BfEL 91112 and E. faecalis BfEL 
90519. L. plantarum IS2 and L. fermentum IS11 inhibited the growth of E. aerogenes 
BfEL 9805, S. marcescens BfEL 98027, and E. faecalis BfEL 90519, L. plantarum 
IS13 showed inhibitory activity against E. aerogenes BfEL 9805, S. marcescens BfEL 
98027, S. aureus BfEL 91161, and E. faecalis BfEL 90519. In addition, L. fermentum 
IS15 and L. fermentum IS16 were active against E. aerogenes BfEL 9805, S. 
epidermidis  BfEL 91112 and E. faecalis BfEL 90519. L. fermentum IS12 and L. 
rhamnosus ISO4 only showed activity against E. faecalis BfEL 90519. On the other 
hand, L. johnsonii BfEL 92170, L. paracasei ISO1, 3; L. rhamnosus ISO2, 5, 6,7 
strains did not show any antimicrobial activity against any of the eight indicator 
pathogens.  
Production of a variety of substances by probiotic bacteria with antibacterial 
properties including organic acids, hydrogen peroxide, bacteriocins are considered 
important factors for selecting probiotic strains (Rolfe 2000). The inhibitory effect 
shown by some Lactobacillus strains might be due to the presence of bacteriocins or 
metabolites similar to them. Many authors already have reported that production of 
bacteriocins by lactobacilli is relatively common; this fact may contribute to their 
ability to colonize their habitats and to their competitive edge over other bacteria 
(González et al. 2007; Garriga et al. 1993). The antibacterial activities seem to be 
affected by different factors and the activities vary with respect to strength and action 
spectrum (Olivares et al. 2006; González et al. 2007). Our results showed, that 
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most of Lactobacillus strains had antibacterial effect against Enterococcus faecalis 
BfEL 90519 (Fig. 30). Enterococcus faecalis accounts for the majority of enterococcal 
infections in humans (Tailor et al. 1993, Huycke et al.; 1998 and Charteries et al. 
2001). 
 
Fig. 29: Antimicrobial activity of Lactobacillus strains against Staphylococcus aureus BfEL 
91161and Staphylococcus epidermis BfEL 91112 
A: 10 µl of lactobacillus broth cultures; B: 10 µl of supernatant without adjusting the pH (actual pH  ≈ 
4); C: 10 µl of supernatant with adjusting the pH to ≈ 7. 1: L. gasseri BfEL 92075; 2: L. brevis BfEL 
92026; 3: L. rahmnosus BfEL 92149; 4: L. plantarum BfEL 92122; 5: L. plantarum (A); 6: L. plantarum 
(C); 7: L. plantarum (D); 8: L. plantarum (E); 9: L. acidophilus BfEL 92015; 10: L. johnsonii BfEL 
92170; 11: L. amylovorus BfEL 92203; 12: L. casei BfEL92040 
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Fig. 30: Antimicrobial activity of Lactobacillus strains against pathogenic bacteria 
after changing the lactobacilli overnight culture growth conditions.  
A: E. coli BfEL 98082; B: Enterobacter aerogenes BfEL 9805; C: Serratia marcescens 
BfEL 98027; D: Staphylococcus aureus BfEL 91161; E: Staphylococcus epidermidis  
BfEL 91112 ; F: Enterococcus faecalis BfEL 90519; G: Salmonella typhimurum; H: 
Listeria monocytogenes; 1: L. gasseri BfEL 92075; 2: L. brevis BfEL 92026; 3: L. 
rahmnosus BfEL 92149; 4: L. plantarum BfEL 92122; 5: L. plantarum (A); 6: L. plantarum 
(C); 7: L. plantarum (D); 8: L. plantarum (E); 9: L. acidophilus BfEL 92015; 10: L. 
johnsonii BfEL 92170; 11: L. amylovorus BfEL 92203; 12: L. casei BfEL92040. 
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Table 18: Antimicrobial activity of Lactobacillus strains against eight indicator strains* 
Lactobacillus strains 
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Diameter of inhibition zones (mm) 
L. gasseri BfEL 92075 8 9 9 15 11 10 10 8 
L. brevis BfEL 92026 9 9 9 16 10 10 9 8 
L. rhamnosus BfEL 92149   - - - 12 10 - - - 
L. plantarum BfEL 92122 9 10 10 10 10 10 10 8 
L. plantarum  (A) 9 10 10 12 10 10 10 9 
L. plantarum (C) - 9 10 15 9 - 10 - 
L. plantarum (D) - 10 9 15 11 10 10 8 
L. plantarum (E) 8 9 9 15 10 9 9 8 
L. acidophilus BfEL 92015   - - - 16 - - - - 
L. johnsonii BfEL 92170 - - - - - - - - 
L. amylovorus BfEL 92203 - - - 15 14 - - - 
L. casei BfEL 92040 9 9 10 15 12 11 10 8 
L. fermentum IS1 - 9 12 12 10 11 - - 
L. plantarum IS2 - 8 10 - - 10 - - 
L. fermentum IS 11 - 12 10 - - 10 - - 
L. fermentum IS12 - - - - - 8 - - 
L. plantarum  IS13 - 11 10 10 - 9 - - 
L. fermentum IS15 - 10 - - 10 10 - - 
L. fermentum IS16 - 11 - - 10 11 - - 
L. paracasei ISO1 - - - - - - - - 
L. rhamnosus ISO2   - - - - - - - - 
L. paracasei ISO3 - - - - - - - - 
L. rhamnosus ISO4 - - - - - 11 - - 
L. rhamnosus ISO5 - - - - - - - - 
L. rhamnosus ISO6 - - - - - - - - 
L. rhamnosus ISO7 - - - - - - - - 
* The total diameter was measured, including the flter disc (6 mm).  
-   No inhibition zone around filter disc observed.  
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4.2.4 Antibiotic susceptibility  
Fermented foods may be regarded as important vehicles transfering enormous 
amounts of living bacteria into the human body. These bacteria may carry antibiotic 
resistances, which might be transferred to commensal or pathogenic bacteria. The 
presence of transmissible antibiotic resistance markers of strains is thus an important 
safety criterion (Hummel et al., 2007). There are no approved standards for testing 
phenotypic antibiotic susceptibility in most food isolates (Kastner et al., 2006; 
Danielsen and Wind, 2003).   
4.2.4.1 Susceptibility to inhibitors of cell wall synthesis  
Fig. 31 shows the susceptibility of 26 lactobacilli strains against inhibitors of cell wall 
synthesis (ampicillin, cefotaxime, methicillin and vancomycin). All strains were very 
sensitive to ampicillin. Expect L. rhamnosus BfEL92149 and L. plantarum 
BfEL92122, which were resistant, most of the strains were also sensitive or 
moderately susceptible to cefotaxime. In addition, the majority of strains were 
resistant to vancomycin including all strains isolated from the Egyptian dairy products 
and 3 strains from infant isolates. Only eight strains were sensitive to vancomycin (L. 
brevis BfEL92026, L. acidophilus BfEL92015, L. johnsonii BfEL92170, L. amylovorus 
BfEL92203, L. paracasei ISO3, L. rhamnosus ISO4, L. rhamnosus ISO5, L. 
rhamnosus ISO7). Most of the strains were resistant to methicillin including L. gasseri 
BfEL92075, L. brevis BfEL92026, L. plantarum BfEL92122 and all strains isolated 
from the Egyptian dairy products and L. rhamnosus ISO7 from infant isolates. The 
rest of strains ranged from moderate sensitive to sensitive. 
4.2.4.2  Susceptibility to inhibitors of protein synthesis  
Fig. 32 shows the susceptibility of 26 lactobacilli strains against inhibitors of protein 
synthesis (gentamycin, kanamycin, streptomycin, tetracycline, chloramophenicol, 
erythromycin, lincomycin and neomycin). Almost all strains were very sensitive to 
gentamycin, except L. fermentum IS1, L. rhamnosus ISO5 and L. rhamnosus ISO7, 
which were resistant. Fifteen strains exhibited resistance to kanamycin including five 
from the infant isolates. Only L. plantarum (D) strain was very sensitive to kanamycin; 
the rest was moderately susceptible. Most of the Lactobacillus strains revealed 
resistance to streptomycin. These comprise five strains from the infant isolates, eight 
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strains from Egyptian dairy products and three of BfEL strains. L. amylovorus BfEL 
92203 was highly sensitive to streptomycin. Twelve strains were sensitive, three 
moderate sinsitive and eleven revealed resistance to tetracycline. All investigated 
strains showed resistance to chloramophenicol except L. rhamnosus BfEL 92149 
which was moderately susceptible. The same situation was observed for 
erythromycin. All strains were sensitive excluding L. fermentum IS12, which was 
moderately susceptible. Ten strains were resistant against lincomycin. The rest of the 
strains ranged from highly to moderate sensitive. Almost the same results were 
obtained for neomycin where eleven strains were resistant and the rest ranged from 
highly to moderately sensitive. 
4.2.4.3 Susceptibility to Inhibitor of nucleic acid synthesis 
Fig. 33 shows the susceptibility of 26 lactobacilli strains to inhibitor of nucleic acid 
synthesis (Ofloxacin). Most strains were resistant to ofloxacin, including all strains 
isolated from the Egyptian dairy products, most the BfEL strains and two strains from 
infant isolates. L. casei BfEL 92040, L. rhamnosus ISO2, 4, 5, 6, 7, L. paracasei ISO3 
were sensitive; L. acidophilus BfEL 92015 was moderately sensitive, respectively. 
The rest of the infant isolates were sensitive to ofloxacin. 
In the present study, all the tested Lactobacillus strains were sensitive to the clinically 
relevant antibiotics ampicillin, erythromycin, chloramophenicol and cefotaxime. These 
results confirm those reported by Hummel et al., (2007), who found, that most of 
Lactobacillus strains were quite sensitive to these antibiotics. On the other hand, our 
findings revealed that 88.5% of strains were sensitive to gentamycin. This result is in 
contrast to observations by Hummel et al., (2007). This difference may be due to 
different isolation of strains from different environments. Moreover, 69% of strains 
were resistant to vancomycin. Among the 31% showing sensitivity were L. 
acidophilus and the very related L. johnsonii. These results are consistent with those 
of Hamilton-Miller and Shah, (1998), who found that more than 60% of 
Lactobacillus strains were resistant to vancomycin, while L. acidophilus was 
sensitive. Antibiotic concentrations, used for determination of antibiotic susceptibility, 
were higher than the values reached in blood serum: e. g. the blood serum 
concentrations for erythromycin; tetracycline and chloramophenicol were 2-3, 8, 10-
15mg/ml, respectively (Hummel et al., 2007; Yao and Moellering, 1995). 
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Susceptibility determination at concentrations higher than these values is only of 
academic interest. We conclude that safety evaluation of probiotics used in dairy 
fermentations should be intensified because the role of probiotics in potentially 
spreading antibiotic resistance gene is still unclear as is their effect on the host under 
conditions of antibiotic treatment. 
 
 
Fig. 31: Lactobacillus susceptibility to inhibitors of cell wall synthesis   
(ampicillin, cefotaxime, Methicillin and vancomycin). Scale indicates inhibition zone in mm. 
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(A) 
 (B)  
Fig. 32: Lactobacillus susceptibility to inhibitors of protein synthesis 
(A)gentamycin, kanamycin, streptomycin and tetracycline; (B) chloramophenicol, 
erythromycin, lincomycin and neomycin. See legened of Fig. 31  
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Fig. 33: Lactobacillus susceptibility to inhibitors of nucleic acid synthesis 
 (Ofloxacin). See legened of fig. 31 
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5 Chapter III   
 Cloning of a conjugated bile salt hydrolase gene (cbh) from 
Lactobacillus plantarum in Lactobacillus /E. coli shuttle vectors 
and expression of this gene in different Lactobacillus strains. 
5.1 Introduction  
Bile salts, the water-soluble end products of cholesterol metabolism in the liver, have 
amphipathic properties through which they play an important role in the digestive 
processes. Bile acids are synthesized from cholesterol and conjugated to either 
glycine or taurine in the liver (Savage et al., 1995) and are subsequently stored in 
the gall bladder. In response to the ingestion of food, bile salts are released into the 
duodenum helping fat digestion and absorption (Dussurget et al., 2002). In addition 
to their role in digestion, bile salts have antimicrobial properties. Bile salts are 
amphipathic molecules, which can destroy lipid-containing bacterial and viral 
membranes. Some resident enteric microflora and intestinal pathogens have evolved 
mechanisms to resist the detergent action of bile salts by preventing or reduce entry 
into the cells (Gunn, 2000). Other gastrointestinal bacteria of several genera, 
including Bacteroides, Clostridium, Enterococcus, Bifidobacterium and Lactobacillus 
produce bile salt hydrolases. The first step in bacterial bile salt metabolism is 
hydrolysis of the amide bond by which the glycine and/or taurine moiety is released 
from the side chain of the bile salt steroid core. Bile salt hydrolysis, resulting in 
deconjugated bile salts, is an important bile salt modification mediated by a wide 
range of colonic anaerobes (Hill, 1995). These enzymes are known as conjugated 
bile salt hydrolase (CBH) or (BSH). Bile salts are biotransformed into a number of 
metabolites by the intestinal microflora of man and animals (Hylemon, 1985). The 
hydrolysis of conjugated bile acids is one of the most common microbial bile salt 
biotransformations. There are to two major hypotheses to explain the function of 
bacterial CBH s. One hypothesis states that bacteria of those species that are able to 
deconjugated bile salts may be able to use the amino acid taurine as an electron 
acceptor. Evidence which supports this hypothesis has been obtained for certain 
Clostridium species (Huijghebaert et al.,1982; Huis In’t Veld and Shortt,1996). The 
second hypothesis states that CBH s decrease the toxidity of conjugated bile acid for 
bacteria (Savage, 1992). 
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It has been also suggested that CBHs are detergent shock proteins, that protect the 
bacteria from the toxidity of bile acids in the gastrointestinal tract (Adamowicz et al., 
1991; Flahaut, et al., 1996; De Boever et al., 2000; Grill et al., 2000 a,b). 
Phenotypic and genetic screens revealed that bile salt hydrolase activity was 
acquired horizontally in lactobacilli. Lactobacilli within the species acidophilus, brevis, 
buchneri, fermentum, gasseri and plantarum express a variable bile salt hydrolase 
phenotype. PCR screening within L. acidophilus and L. delbrueckii subsp. bulgaricus 
also produced variable results (Elkin et al., 2001). 
A major consideration in the choice of probiotic strains is its property to survive and 
establish itself under the conditions of the intestinal environment. Resistance of bile 
acids is, therefore, an important characteristic for the selection of probiotic strain that 
enables it to survive and grow and exert its action in intestine (Moser and Savage, 
2001; Dussurget et al., 2002).  
The aim of this chapter was to screen strains of several Lactobacillus species for bile 
salt hydrolase activity and to identify the encoding gene for cloning in different shuttle 
vectors and for transformation in lactobacilli. 
5.2 Results and discussion 
5.2.1 Detection of genes (cbh) encoding bile salts hydrolase activity  
In the previous chapter, it was concluded that most of lactobacilli have bile salts 
hydrolase activity and can survive and grow in the presence of bile salts. To identify 
the responsible genes, primers were designed using data available in Gene-Bank 
and sequence analysis application software (OMIGA). EcoRI restriction sites were 
added to the primers to facilitate sub-cloning of the cbh gene. Chromosomal DNA of 
twelve Lactobacillus strains was used for screening and amplification of the cbh 
genes. Only from one strain - Lactobacillus plantarum BfEL92122- a 1392 bp PCR-
amplicon was obtained (Fig. 34). 
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Fig. 34: PCR amplification of cbh gene from 
Lactobacillus plantarum   (BfEL92122). 
M: λ StyI; lane1: PCR amplicon of cbh gene. Arrow 
indicates cbh amplicon 
5.2.2 Cloning of the cbh and expression in E. coli 
The amplified DNA was purified and ligated into pGEM-T-easy vector resulting 
plasmid pS1. Cloning into pBSK, after digestion with EcoRI yielded plasmid pS2. For 
transformation, electro-competent cells of E. coli easypores were used. 
Transformants were identified by blue/white colony screening (Fig. 35 A and B). 
 
(A) 
 
 (B)  
Fig. 35: Plasmids isolated from transformants obtained after cloning of cbh gene of L. 
plantarum BfEL 92122 into vectors pGEM-T-easy 
(A) and pBluescriptII SK+ (B). M: λ StyI; lane 1:  control vector; lanes 2-10: clones of cbh 
gene fragment. 
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5.2.3 DNA sequencing 
 Inserted DNAs from two plasmids were sequenced using T7 and SP6 specific 
primers. The sequences were compared with NBCI data. Data revealed that the cbh 
gene of L. plantarum BfEL 92122 had a similarity of 99% with cbh gene of L. 
plantarum 80. 
5.2.4 Expression of cbh in E. coli  
Expression of cbh gene in E. coli easypores was analyzed by streaking transformants 
harboring plasmid pS1 or pS2 onto LB-agar medium containing 0.5%TDCA and 
0.5%GDCA, respectively. Transformants with plasmid pS2 apparently expressed cbh 
causing deconjugate taurine- and glycine-bile acid forming precipitates on plates, as 
seen in figures B and C of Fig. 36. 
 
     A          B               C 
 Fig. 36: Expression of cbh gene in E. coli. 
A: LB medium; B: LB medium + 0.5% TDCA; C: LB medium + 
0.5% GDCA; 1&2: pS1clones; 3&4:  pS2 clones; L4: control 
carrying only vector pGEM-T-easy; L5: control carrying only 
vector pBSK. 
5.2.5 Cloning of the cbh into Lactobacillus / E. coli shuttle vectors 
5.2.5.1 Cloning and transformation of cbh gene into E. coli 
The cbh amplicon from Lactobacillus plantarum (BfEL 92122) was cloned in pL120 
(see Fig. 41) an E. coli-Lactobacillus shuttle vector and transformed into E. coli Nova 
Blue. Colonies grown on LB medium containing 100µg/ml Amp and 100µg/ml Em 
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were streaked on LB agar medium containing antibiotics and 0.5% TDCA. 
Transformants, producing a precipitate (Fig. 37), were chosen for plasmid analysis 
(Fig. 38). The presence of the cbh gene fragment was confirmed by EcoRI restriction 
enzyme (Fig. 39). Orientation of cbh was determined by HindIII restriction digestion, 
(Fig. 36). In plasmid pS3A (Fig. 41), cbh was cloned in the same orientation as the 
mob promoter, in pL120 and in plasmid pS3B, cbh was cloned in the opposite 
orientation. 
 
Fig. 37: Selection of positive clones on TDCA- LB agar medium 
 
 
Fig. 38: Isolation of plasmids from selected positive transformants. 
M: λ StyI; lanes 1-10: positive clones; C: control plasmid pL120 
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Fig. 39: Conformation of the presence of the cbh gene fragment in the constructed plasmid 
pS3. 
M: λ StyI; lanes 1-10: positive clones; C: control plasmid pL120 
 
Fig. 40: Orientation of the cloned cbh gene by using HindIII restriction enzyme. 
M: λ StyI; lanes 1-10: positive clones; C: control plasmid pL120. 
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Fig. 41: Construction of pS3A and pS3B 
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5.2.6 Expression of cbh in Lactobacillus 
5.2.6.1 Transformation of pS3A and pS3B into Lactobacillus casei LK1 
The two plasmid constructs pS3A and pS3B, were introduced into electro-competent 
Lactobacillus casei LK1 (B. Henrich, personal communication) by electroporation. 
Transformants were grown on MRS agar medium containing 10µg/ml erythromycin. 
Colonies were picked up and streaked on MRS agar plates containing 10µg/ml 
erythromycin and 0.5% TDCA (Fig. 42, 43). Expression of the cbh was higher in 
transformants carrying pS3A (cbh gene in the same direction of mob. promoter) than 
in those with pS3B (cbh gene in the opposite orientation of mob. promoter). Presence 
of proper plasmids was confirmed by agarose gel electrophoresis (Fig. 43). 
 
Fig. 42: Expression of cbh from plasmids pS3A and pS3B after 
transformation into Lactobacillus casei LK1 with plasmids. 
Arrows refer to transformants with pL120 as negative control 
 
 
Fig. 43: Isolation of clones DNA from Lactobacillus casei LK1 
M: λ StyI; C: control plasmid; lanes 1-5: positive clones of plasmid pS3A; lanes 6-10: 
positive clones of plasmid pS3B d pL120  
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5.2.6.2 Transformation into Lactobacillus gasseri 
Several attempts to transform pS3A or pS3B into Lactobacillus gasseri using different 
electroporation conditions and erythromycin concentrations from 10µg/ml to 3µg/ml 
failed. Selection for erythromycin resistance seems not to be applicable for L. 
gasseri. Therefore, selection for chloramophenicol (Cm) resistance was tested. 
Transformation of pGK12 (Fig. 44) which contains a Cm-resistance gene, into L. 
gasseri using different electroporation conditions (0.63, 1, 1.25, 1.5, 2 and 2.5KV / 
cm), resulted in many Cm-resistant clones, which all carried pGK12 (not shown) 
Therefore, we tried to construct a new shuttle vector with a chloramophenicol 
resistance gene as a selective marker.   
                                        
 
 
 
 
 
5.2.7 Construction of a new shuttle vector with a chloramophenicol resistance 
gene as a selective marker 
Plasmid pS3A was digested with SacI and PvuI restriction enzymes (Fig. 45). The  
resulting 3.7 Kb SacI fragment containing  the cbh , repA genes and the promoter of 
mob was cloned in both orientations into SacI linearised pBluescriptII SK+ (pBSK). E. 
coli Nova Blue competent cells were transformed. Transformants, selected by blue-
white selection, were tested for the expression of the cbh. Expression was dependent 
on the orientation (Fig. 46). Plasmids representing both orientations were named 
pL9-1 and pL9-3, respectively. Clones carrying recombinant plasmid with the cbh 
gene in the opposite direction of lac-promoter of the vector (pL9-1) showed high 
expression, whereas those with cbh gene in the other orientation (pL9-3) didn’t show 
expression at all (Fig. 47 and 48).  
Sartakova et al.; 
2000 
Fig. 44: Map of pGK12 
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Fig. 45: Double digest of pS3A with SacI and PvuI.  
M: λ StyI; lane1: pS3A digested with SacI and PvuI; lane 2: undigested plasmid 
 
 
Fig. 46: Expression of cbh gene into pL9 plasmids. 
upper left: pL9-1 (cloned fragment in the opposite direction to 
the lac promoter of pBSK+); upper right:  pL9-3 (cloned 
fragment in the same direction as the lac promoter of pBSK+); 
under left: clone which contains only the vector; under right: 
positive control. 
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Fig. 47: Orientation of the cloned 3.7kb SacI fragment by NotI restriction 
enzyme. 
M: λ StyI; lane1: pL9 – 1; lane2: pL9 – 3 
 
 
 
Fig. 48: Physical maps of plasmids pL9-1 and pL9-3 
 
5.2.7.1 Cloning of the cat-194 gene as a blunted ended fragment into the NcoI 
site of pL9-1 and pL9-3 
Plasmid pL9-1 was linearised with NcoI, blunted with T4-polymerase, 
dephosphorylated and purified (Fig. 49). The chloramophenicol resistance gene from 
Staphylococcus aureus was isolated after digested digestion of pCAT with NotI as a 
925 bp fragment and subsequent agarose gel electrophoresis (Fig. 49). After blunt 
end ligation, E. coli easy pores cells were transformed with the ligation mix by 
electroporation.  Chloramophenicol-resistant clones were selected and tested for cbh 
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expression (Fig. 50). One of the clones 11 showing high cbh–activity, was shown to 
have the cat gene cloned in the same direction as the cbh gene (Fig. 51 and 52)  
 
Fig. 49: : Blunting of pL9-1 and cat-194 gene fragment ends 
M: λ StyI; lane1: cat fragment; lane 2: pL9-1  
 
 
Medium: Lb + Amp + Cm + TDCA 
Fig. 50: Expression of the cbh gene in E. coli easy 
pore clones transformed with ligation mix 11. 
1-15 different transformants picked up after transformation. 
 
 
After 
purification 
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Fig. 51: : Restriction of pL11 with BveI restriction 
enzyme. 
M λ StyI; lane 1: clone of pL11; lane 15: undigested pL11. 
 
5.2.7.2 Orientation detection of the cat194-gene into plasmid pL11  
Ligation after blunting NotI and NcoI ends created new NcoI sites in pL11.Thus, the 
cat gene can be easily repleased by another antibiotic resistance gene (Fig. 20). 
 
Fig. 52: Orientation of cat194 gene in pL11 
 
 
5.2.8 Cloning of cbh in pGKV2 
This vector based on the broad host-range replicon of pWG2, a Lactococcus lactis 
plasmid (Fig. 53) replicates in various Gram-positive and -negative bacteria, as e.g. 
in Lactobacillus and E. coli. The cbh amplicon was ligated into the single EcoRI–site 
of the pGKV2 and transformed into E. coli Nova blue chemical competent cells. 
Transformants were selected on LB-agar plates supplemented with 100µg/ml Em + 
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5µg/ml Cm, or on plates, containing 0.5% TDCA in addition to antibiotics. On agar 
plates containing 0.5% TDCA cbh expressing clones were easily recognized by a 
precipitate around the colonies (Fig. 54). All transformants tested carried a plasmid of 
the expected size (not shown), which contained a cloned fragment of about 1500bp 
(Fig. 55).  
 
Fig. 53: Restriction map of pGKV2 (Kok et al., 1985) 
 
 
 
Fig. 54: Transformation and expression of the cbh gene cloned in pGKV2 in E. coli 
Nova-Blue 
 
 
Fig. 55: EcoRI digest of L14 Clones (plasmid pL14). 
M: λ StyI; lane1: EcoRI digest of pGKV2; lanes 2-9: EcoRI digest of transformants 
plasmids; lane10: undigested pGKV2   
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5.2.9 Transformation and expression of cbh in Lactobacillus 
By optimizing the transformation conditions for L. casei and L. gasseri, we succeeded 
to transform these two strains with the newly constructed plasmids pS3A, pL11 and 
pL14. In addition, L. rhamnosus was transformed with pL11. Successful 
transformation was obtained with a Biorad Gene Pulser at electric field strength of 
10KV/cm for L. gasseri and L. rhamnosus, and 12.5KV/cm for L. casei, a capacity of 
25µF and at 200Ω in 0.1cm cuvettes. To phenotypically express Em or Cm 
resistance, electroporated cells were incubated for 4-5 hrs at 37°C in MRS medium, 
supplemented with 3ng/ml Em or Cm, respectively. By applying these conditions, 
plasmids pS3A, pL11 and pL14 were transformed into L. casei, L. gasseri and L. 
rhamnosus (Fig. 56 and Table 19). All transformants expressed cbh and were able to 
deconjugated taurine and glycine-bile acid, resulting in a precipitate from deoxycolic 
acid around colonies on MRS agar plates, supplemented with 0.5% TDCA or 0.5% 
GDCA (Fig. 58). EcoRI-digestion of plasmids isolated from transformants confirmed 
the structural integrity of these plasmids (see e.g. Fig. 57 for L. gasseri). 
Segregational stability of plasmids pL11 and pL14 was tested. Plasmid pL11 in L. 
gasseri showed stability of 60, 25 and 6% after 70,140 and 210 generation, 
respectively. In L. casei the corresponding values were 56, 15 and 2%, respectively. 
Plasmid pL14 was less stable and was almost completely lost from L. gasseri after 
140 generation (Table 20). 
 
 
Fig. 56: Isolation of recombinant plasmids carrying the cbh gene from Lactobacillus plantarum 
BfEL 92122 after transformation into Lactobacillus strains. 
M: λ StyI; lane C1: pS3A control; lanes G1: group of L. casei transformed with pS3A; lanes G2: group 
of L. gasseri transformed with pS3A; lane C2: pL11 control; lanes G3: group of L. casei transformed 
with pL11; lanes G4: group of L. gasseri transformed with pL11; lane C3: pL14 control; lanes G5: 
group of L. gasseri transformed with pL14 
 
 
  Chapter III 
120 
 
 
Fig. 57: EcoRI digest of plasmids isolated from L. gasseri 
transformed with plasmid pL14. 
 M: λ StyI; lanes 1 – 3: EcoRI digest of pL14 isolated from L. 
gasseri transformants; lane 4: undigested pL14 as a control. Arrow 
refers to cbh gene fragment.  
        
 
 
Fig.58: Expression of cbh gene which constructed in different plasmids and transformed 
into Lactobacillus sp. 
 
 
.
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Table 19: List of transformed strains 
Constructed  
plasmids 
Description / relevant 
phenotype 
Transformation cbh  gene Expression 
E. 
coli 
L. 
casei 
L. 
gasseri 
L. 
rhamnosus 
E.   
coli 
L. 
casei 
L. 
gasseri 
L. 
rhamnosus 
pS3A 
Replicon pSMA53, cbh+, 
Em+, Ap+ 
+ + + NT + + + NT 
pL9-1 
Replicon pSMA53, 3.7 kb 
SacI fragment (cbh+ 
;rep+;mob+) cloned in 
pBluescript IISK+ ; Ap+ 
+ NS NS NS + NS NS NS 
pL11 
Replicon pSA53, blunted 
cat194 gene cloned in pL9-1;  
Ap+; cat+ 
+ + + + + + + + 
pL14 
Replicon pGKV2, cbh+  Em+; 
cat+ 
+ + + NT + + + NT 
    NS: Antibiotic selective marker not suitable     NT: Not tested           +: transformants obtained       
  
C
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Table 20: Segregational stability of the recombinant plasmid 
Time/generationa)  
pL11/ L. gasseri Stability 
%b) 
pL11/ L. casei Stability 
%b) 
pL14/ L. gasseri Stability 
%b) 
-AB +AB -AB +AB -AB +AB 
1st week / 50 37.4X109  22.5X109  60 34.6X109 19.3X109 55 39.5X108 12.5X108 31.6 
 
2ed week / 100 
 
12X108 
 
3X108  25 41X108 6X108 14.6 22.5X107 2.5X106 
 
       1.1 
3rd week / 150 35X108  22.2X107  6.34 47.6X108 9X107 1.9 4X106 22X107 1.8 
        a)
 Approximate number of generations   b) Segregational stability [CFU+AB / CFU–AB X100] %     +AB; -AB with and without antibiotic 
                    
C
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r
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5.2.10 Determination of bile salts tolerance 
To evaluate the ability to survive and/or grow in the presence of bile, the parent 
strains of L. casei, L. gasseri and L. rhamnosus and their transformants carrying cbh 
on plasmid pL11 were compared for survival and growth in MRS medium 
supplemented with 0.5 or 1% GDCA. The cell numbers of all wild type strains 
decreased rapidly after inoculation in the presence of bile salts, whereas 
transformants of these strains even showed slight increases (2-4 folds) in cell 
numbers (Figs. 59-61). This clearly indicates that the cbh gene was expressed in 
these Lactobacillus strains and that the bile salt hydrolase protects the cells against 
the detrimental effects of the bile salt. The estimated bile concentration in the 
gastrointestinal tract is about 0.3%, significantly lower than the concentrations used 
in these experiments. From this we suppose, that the introduction and expression of 
a cbh gene will increase the survival of lactobacilli in the gut.  
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Fig. 59: Growth and survival of L. gasseri and its transformant L. gasseri (pL11) in presence of 
GDCA 
.
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Fig. 60: Growth and survival of L. casei and its transformant L. casei (pL11) in presence of 
GDCA 
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Fig. 61: Growth and survival of L. rhamnosus and its transformant L. rhamnosus (pL11) in 
presence of GDCA.
 
 
5.2.11 Use of the cbh gene of Lactobacillus plantarum BfEL 92122 as a food 
grade indicator gene 
The cbh gene from Lactobacillus plantarum, when cloned into appropriate shuttle 
vectors, was over-expressed in E. coli to an extent, that transformants could be 
identified directly on indicator plates containing bile salts as substrate (see Fig. 62). 
This was verified by transforming competent E. coli Nova-Blue cells either with 
ligation mixes containing vector and cbh gene fragment or with intact recombinant 
plasmids, carrying the cbh gene (Fig. 63). After transformation, the cells were 
incubated at 37°C for 60 min and plated directly or serially diluted onto LB agar 
medium supplemented with 0.5% TDCA or GDCA, respectively. Incubation of the 
plates for 24 to 48h at 37°C, colonies of transformed cells were due to the activity of 
the bile salt hydrolase, surrounded by a less soluble precipitated of free deoxycholic 
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acid. The very obvious phenotype of cbh expressing cells on plates supplemented 
with conjugated bile salts attempted us to test cbh to be used as selective marker. 
Fig. 62 shows that cbh acts very well as indicator gene. Therefore, selection based 
on cbh could not be demonstrated so far (data not shown).   
 
Fig. 62: Transformation of E. coli Nova-Blue with the plasmid pL11 and 
plating onto LB agar medium supplemented with GDCA without any 
antibiotics A: after 24 hours incubation; B: after 48 hours incubation. 
 
 
 
Fig. 63: Isolation of plasmid pL11 from E. coli transformants. 
M: λ StyI; lane 1: control; lanes 2 & 3: pL11 from positive transformants with antibiotics; lanes 4 & 5: 
pL11 from positive transformants without antibiotics; lanes 6 &7: pL11 from positive transformants 
without antibiotics and with ox-gall. 
 
10-4 10-5 
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6 Chapter IV 
 Lysogeny and autolysis of lactobacilli.  Analysis of temperate 
phage of Lactobacillus gasseri BfEL 92075 
6.1 Introduction 
For effective application of probiotic strains, lysogeny and autolysis are, especially in 
terms of stability of the cultures, undesirable properties. Although lysogeny is 
widespread in lactobacilli, relatively little information on this topic is available for 
many potentially probiotic lactobacilli. Dependent on the species, strains inducible for 
phage range from 10-80 %, but complete temperate phages are present less 
frequently (Carminati et al., 1997; Stetter, 1977; Yokokura et al., 1974). Several 
temperate phages (FSW, A2, Øg1e) have been isolated from Lactobacillus strains 
used in dairy fermentations (Brüssow, 2001). So far, data on Lactobacillus gasseri 
temperate phages are very rare. Only phi ADH, isolated from Lactobacillus gasseri 
ADH, has been well characterized. It belongs to the morphtype B1 siphovirus with 
double stranded linear DNA (Raya et al., 1989). Here, we describe a second 
temperate bacteriophage - phi Lbgas1- from Lactobacillus gasseri BfEL 92075. In 
addition, a method to cure the wild-type strain from its prophage will be presented. 
6.2 Results and discussion 
6.2.1 Lysogeny and autolysis in Lactobacillus sp. 
Eleven strains belonging to six Lactobacillus species were examined for autolysis in a 
standard buffer system (NiIskasaari, 1989; Yokoi et al., 2004) and for induction of 
prophages after treatment with mitomycin C (MC). Although MC-induced lysis was 
observed with five strains, intact phage particles were only found in the lysates of L. 
gasseri strains BfEL 92075 and NCK 102-adh by electron microscopy. These phages 
could be propagated only in the prophage-cured derivatives BfEL 92075-1 and NCK 
of the parent strains, respectively. L. gasseri NCK 102-adh and its prophage-cured 
derivative NCK 102 (B. Henrich, personal communication) were used as control 
strains throughout these experiments.  
The efficiency of induction of L. gasseri BfEL 92075 was dependent on MC- and Ca++ 
-concentration, and on the cell density at the time of MC addition. Best induction in 
MRS-medium was observed at a low cell density (OD620<0.25), MC-concentration of 
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0.1 to 0.4 µg/ml and a Ca++- concentration of 10 mM. Several attempts to induce the 
strain by UV irradiation always showed incomplete lysis (data not shown). 
Autolysis of bacteria is caused by specific, mostly cell-wall-associated enzymes, 
peptidoglycan hydrolases. In lysogenic strains induction of an intact or even a 
defective prophage may similate autolysis. The lytic system of the prophage is then, 
at least partially, responsible for the host strain lysis. Autolytic activities of all strains 
used for induction experiments were determined after transfer of stationary phase 
bacteria into buffer solution at 37°C. The extent of autolysis differed significantly, 
revealing a species and strain dependency of the autolytic behaviour. After curing of 
its prophage (shown later), L. gasseri BfEL 92075 lost the autolytic activity almost 
completely. A non MC-inducible, but not completely prophage-cured derivative of this 
strain showed autolysis only after prolonged incubation. In addition, large amounts of 
defective phage particles were detected in the lysates of strongly autolytic L. brevis 
strains, indicating that mainly phage-encoded enzymes were responsible for autolysis 
in these lactobacilli. Our results were in agreement of those by Yokoi et al., 2004, 
who suggested that phage encoded lysine and bacterial lytic enzymes act additively 
in autolysis of L. gasseri cells. Although NCK102 strain is non-inducible, it still 
contains lysis genes. As shown below, this result may be explained by presence of 
phi Lbgas1 DNA in the chromosomal DNA of L. gasseri NCK102-Adh and L. gasseri 
NCK102. The results are summarized in Table 21 and in Fig. 64 and 65. 
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Table 21: Lysogeny and autolysis of Lactobacillus sp. 
 
a): -) no induction of prophage;  +) induction:  
b): +) infectious phage; +d) >99% defective phage particles 
c): -) no lysis after 24h; (+)) weak lysis after 24h; +) incomplete lysis after 24h; ++) 
complete   lysis after 2h; +++) complete lysis after 1h. 
1): prophage-cured derivative of L. gasseri BfEL 92075 
2): non MC-inducible derivative of L. gasseri BfEL 92075 
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Fig. 64: Autolysis of Lactobacillus sp. 
Cells were resuspended in autolysis buffer (10mM Tris pH7). 
Lactobacillus. 
sp. Strain 
MC-induced 
lysisa 
Phage 
particlesb Autolysis
c
 
L. acidophilus    BfEL 92015      - - - 
L. amylovorus    BfEL 92203 - - - 
L. plantarum     BfEL 92122 - - - 
L. brevis    BfEL 92026 - +d +++ 
L. brevis    BfEL 92027 + - ++ 
L. johnsonii    BfEL 92170 + - + 
L. gasseri    BfEL 92075  + + +++ 
 L. gasseri     BfEL 92075-11 - - - 
L. gasseri    BfEL 92075-22 - - (+) 
L. gasseri    NCK 102-adh + + + 
L. gasseri     NCK 102 - - + 
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Fig. 65: Effect of the MC concentration on induction of L. 
gasseri BfEL 92075 
 
6.2.2 Bacteriophage Lbgas1: Morphology and genome structure 
The phage particles obtained after MC-induction of L. gasseri BfEL 92075 possessed 
isometric, hexagonal heads, contractile tails and a base plate fitted with fibres (Fig. 
66). The sizes of the prophage substructures are summarized in Table 22.  
 
 
Fig. 66: Electron micrographs of phi Lbgas1 (bacteriophage inducible from 
Lactobacillus gasseri BfEL 92075) 
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Table 22: Dimensions* of phage Lbgas1 
Nr. 
Head Neck Tail Sheatha Base plate Fiber 
C/C S/S Width Length Width Length Width Length Width Length 
1 63.5 57.3 12.1 10.1 19.4 176.2 26.1 103.1 27.6 50.9 
2 60.4 55.0 11.7 8.9 20.9 173.6 27.4 106.4 25.1 50.0 
3 64,7 57.9 9.7 10.4 19.2 175.4 25.3 105.8 24.6 39.7 
4 63.5 60.6 12.1 11.1 20.2 179.6 24.5 103.9 23.1 48.0 
5 66,7 53.9 10.7 8.2 21.7 180.9 26.3 100.9 23.0 46.7 
6 60,4 60.2 9.5 8.8 19.3 179.6 24.4 97.8 24.2 46.8 
7 60.1 56.9 9.7 12.2 18.9 178.8 22.8 102.7 21,4 46.3 
8 62.6 59.4 11.3  20.6 179.0 22.9 98.7  38.9 
9 61.3 54.3   18.5  24.2 102.2  50.2 
10 61.7    20.5  22.5 92.3  46.6 
11     19.0  22.0    
12       26.8    
Average 62.5 57.3 10.9 10.0 19.8 177.9 24.6 101.4 24.1 46.4 
a: after tail contraction  C/C : corner to corner  S/S: side to side; * using analySIS 3.2 software (Soft 
Imaging SIS, Münster, Germany) 
For further analysis and characterisation of phage Lbgas1, DNAs of phi Lbgas1 and 
phi ADH were isolated as described in Material and Methods. In addition, 
chromosomal DNAs of L. gasseri BfEL 92075; L. gasseri NCK102-Adh; L. gasseri 
NCK102 were extracted. 
 
6.2.3 Phage DNA restriction analysis 
To characterize phi Lbgas1, the extracted phage DNA was digested with the 
restriction enzymes: EcoRI, HindIII, SalI, HinfI, SpeI, NheI, XbaI, SspI, HpaII and 
EcoRV and the DNA digests were separated on 1.5% and 0.6% agarose gels (Fig 
67A and B), respectively . 
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Fig. 67: Analysis Restriction profiles of the temperate phage phi Lbgas1 total DNA 
into 1.5% agarose gel (A) and 0.6% agarose gel (B). 
M1:100bp Ladder; M2: λSty1; lane 1: EcoRI; lane 2: HindIII; lane 3: SalI;  lane 4: HinfI; 
lane 5: SpeI; lane 6: NheI; lane 7: XbaI; lane 8: SspI; lane 9: HpaII; lane 10: EcoRV. 
  
 
The genome size of phi Lbgas1 was calculated from the DNA restriction patterns by 
estimating the fragments generated by some restriction enzymes, e.g. EcoRI, SpeI 
and NheI, which revealed clear fragment profiles on the agarose gel. The estimated 
genome size was about 44 Kb (see Table 23). 
In addition, heating of phage DNA digests at 74ºC for 5 min (data not shown) 
revealed no differences before and after heating, indicating the absence of cohesive 
ends (Quiberoni et al., 2003). phi Lbgas1 may therefore be considered a phage of 
the pac-type. 
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Table 23: Estimation of phi Lb gas1 genome size 
NO. Fragment Size (kp) 
EcoRI SpeI NheI 
1 12.300 15.500 18.600 
2 11.700 8.150 7.900 
3 7.100 4.500 7.500 
4 3.800 3.950 4.500 
5 3.300 3.250 2.600 
6 3.000 2.550 1.850 
7 2.750 2.100 1000 
8 - 1.700 - 
9 - 1.400 - 
10 - 1.050 - 
Total 43.950 44.150 43.950 
 
6.2.4 Comparative analysis of restriction patterns  
Bacteriophages phi Lbgas1 and phi ADH DNAs were compared by restriction 
analysis using endonucleases HindIII, NheI, SpeI and EcoRV. The restriction 
patterns obtained of phi Lbgas1 were different from those of phi ADH DNA. Although 
these DNA fingerprints revealed that phage phi Lbgas1 from L. gasseri BfEL 92075 
and phage phi ADH from Lactobacillus gasseri NCK102- Adh are genetically 
different, some fragments with identical size were detected. (Fig. 68). 
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Fig. 68: DNA fingerprints of phi Lbgas1 and phi ADH. 
M: λStyI; lane 1: phi Lbgas1+HindIII; lane 2: phi ADH +HindIII; lane 3: phi Lbgas1+NheI; lane 4: phi 
ADH+NheI; lane 5: Phi Lbgas1+SpeI; lane 6: Phi Adh+SpeI; lane 7: phi Lbgas1+EcoRV; lane 8: phi 
ADH + EcoRV. 
6.2.5 SDS-PAGE 
For further characterization of phi Lbgas1, the profile of structural proteins on SDS-
PAGE was studied in comparison with phi ADH protein profile (Fig. 69). The protein 
profile of phi Lbgas1 showed 3 major proteins with estimated molecular masses of 
about 52, 42 and 21 kDa. This protein profile of phi Lbgas1 is completely different 
from the protein profile of the cos-type phi ADH, which revealed two major proteins 
with molecular masses of about 32 and 26 kDa. This result also demonstrates that 
temperate phi Lbgas1 from strain L. gasseri BFEL 92075 is a pac-type phage. It 
appear that L. gasseri phages divide into two groups according to their nature of DNA 
packaging (pac-type e.g. phi Lbgas1 and cos-type e.g. phi ADH) and that this nature 
is reflected by their structural proteins, as it has been for Streptococcus thermophilus 
( Le Marrec et al., 1997; Y. Ali, unpublished data).  
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Fig. 69: SDS-PAGE for phi Lbgas1 and phi ADH. 
M1: pre-stained protein ladder (Invitrogen No. 10748-010; M2:  Protein molecular weight marker 
(Fermentas SM0431); lane 1: phi Lbgas1; lane 2: phi ADH. 
 
6.2.6 Southern blot and hybridization 
Southern blot and hybridization were performed to prove that phi Lbgas1 is 
integrated into the genome of its host L. gasseri BfEL 92075. DNA of phi Lbgas1 was 
hydrolyzed with HindIII or NheI enzymes, labeled and hybridized in a Southern blot to 
HindIII-digested L. gasseri BfEL 92075 DNA (Fig. 70). The hybridization revealed 
differences in the restriction patterns, which are expected when comparing phage 
DNA with prophage DNA (Raya et al., 1992). This proved that L. gasseri strain BfEL 
92075 harbors the temperate phi Lbgas1 as a prophage. 
The relationship between phi Lbgas1 and phi ADH as well as the occurrence of phi 
Lbgas1 homologous sequences in L. gasseri strains were studied. Labeled phi 
Lbgas1 DNA was hybridized to blots of NheI digested DNA of phi ADH, L. gasseri 
NCK102-Adh and L. gasseri NCK102 (cured from ADH prophage) DNA. Both 
temperate phages showed weak homology (Fig.71). However, the chromosomal 
DNA of L. gasseri NCK102 revealed DNA bands efficiently hybridizing with phi 
Lbgas1 probe. This homology may due to presence of parts of phi Lbgas1 in the 
genome of L. gasseri NCK102, or to presence of DNA sequences very similar to phi 
Lbgas1. This result may explain the autolytic behavior of L. gasseri NCK102 (see 
6.2.7), which appears to be caused by hydrolase activities induced from genes on a 
non-inducible or defective phi Lbgas1 prophage.  
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Fig. 70: Southern Blot Hybridization of phi Lbgas1 
DNA and L. gasseri BfEL 92075. 
lane1: HindIII digested DNA of phi Lbgas1; lane 2: 
HindIII digested chromosomal DNA of L. gasseri BfEL 
92075; lane 3:  marker λStyI as a negative control.  
 
 
 
Fig. 71: Southern Blot Hybridization of phi Lbgas1 and phi ADH. 
M: λStyI; lane 1: phi Lbgas1; lane2: phi ADH; lane 3: Chromosomal DNA of L. gasseri BfEL 
92075; lane 4: Chromosomal DNA of L. gasseri NCK102-Adh; lane 5: Chromosomal DNA of L. 
gasseri NCK102. DNA in Lane 1-5 were digested with NheI.   
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6.2.7 PCR analysis for the holin-lysin genes of phi Lbgas1  
Our results had been revealed phi Lbgas1 homologous sequences in L. gasseri 
NCK102 DNA and autolytic behavior of this strain. Therefore, we carried out PCR 
analysis using primers specific for the holin-lysin genes of phi Lbgas1 (Fig. 72). 
Restriction analyses of the holin-lysin gene amplicons of 1477bp generated were 
performed using HapII, XbaI and TaqI restriction enzymes. The results in Fig. 73 
revealed no differences in restriction pattern for the enzymes between all holin-lysin 
genes from phi Lbgas1; phi ADH; L. gasseri BfEL 92075; L. gasseri NCK102- Adh. 
This result confirms that the autolytic behavior of L. gasseri NCK102 (cured from phi 
ADH) is most liklly due to  the presence of holin-lysin expressed from phi Lbgas1 
DNA sequence present in the chromosomal DNA of L. gasseri NCK102. 
.  
 
Fig. 72: PCR amplicons of holing-lysin cassette. 
M: λStyI; lane 1: phi Lbgas1; lane 2: phi ADH; lane 3: L. gasseri 
BfEL 92075; lane 4: L. gasseri NCK102- Adh; lane 5: L. gasseri 
NCK102  
 
 
 
 
Fig. 73: Restriction analysis of holin-lysin gene fragments. 
Fragments of the holin-lysin-operon were amplified by PCR with primers (5´-
CGCAAGAAGGTTAAACGGTTAG-3´) and (5´-CCAG-AGAAACATCTCCAGAGC-3´). 
The resulting 1477bp fragments were digested and analyzed. M: λStyI; lane 1: phi 
Lbgas1; lane 2: phi ADH; lane 3: L. gasseri BfEL 92075; lane 4: L. gasseri NCK102-
Adh; lane 5: L. gasseri NCK102 
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6.2.8 Pro-phage curing from L. gasseri BfEL 92075 
L. gasseri BfEL 92075 was cured from its prophage phi Lbgas1 after MC treatment. 
Selection of MC-resistant derivatives (Fig.74) was only possible in the presence of 
phage-specific antibodies during induction and selection. After induction of strain L. 
gasseri with MC in the presence of anti-phage serum, 30 µl of induced culture were 
plated onto MRS agar plates, surviving cells were streaked in parallel onto LMRS 
agar and LMRS agar containing 0.2 µg MC/ml. The plates were anaerobically 
incubated at 37°C for 72h. From 25 colonies only eight were able to grow in the 
presence of 0.2µg MC/ml. These colonies were inoculated into LMRS broth and 
grown overnight at 37°C. 
 
 
Fig. 74: Selection of Phi Lbgas1-cured derivatives of L. 
gasseri after MC treatment in the presence of anti-phage 
serum. 
  
   
Re-induction of the eight derivatives with 0.2µg MC/ml revealed that only 3 of them 
and the control could be induced again. The other five derivatives could no longer be 
induced by MC (Fig. 75). 
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Fig. 75: Induction of L. gasseri and its derivatives with 0.2µg 
MC/ml. 
Control: L. gasseri BfEL 92075; S1-S5: derivatives of L. gasseri 
isolated after treatment with MC in the presence of phi Lbgas1 
antiserum.   
 
To confirm the descent of the non-inducible derivatives from L. gasseri BfEL 92075, 
ARDRA analysis and SDS-page were done. PCR products of 16-23S rDNA genes 
were restricted wit HaeIII and HinfI. The results revealed that L. gasseri and its five 
non-inducible derivatives showed the same ARDRA patterns (Fig. 76). Also when 
SDS page applied there were no differences between L. gasseri and its five non-
inducible derivatives. See Fig. 77   
 
 
Fig. 76. ARDRA for the lysogenic strain L. gasseri BfEL 92075 and its non-inducible derivatives 
using HaeIII and HinfI restriction enzymes. 
M: λStyI;   lanes 1-5: non-inducible derivatives of L. gasseri BfEL 92075; lane 6: lysogenic strain L. 
gasseri BfEL 92075 
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Fig. 77: Analysis of protein patterns for lysogenic Strain and its derivative. 
M: Pre-stained protein ladder; lane 1: lysogenic strain L. gasseri BfEL 92075; 
lanes 2-6: non-inducible derivatives of L. gasseri BfEL 92075 
 
6.2.9 Southern blot and DNA-DNA hybridization for phi Lbgas1, L. gasseri 
BfEL 92075 and its prophage-cured derivatives 
Southern blot and hybridization were performed to study the relatedness between  
the temperate phi Lbgas1, its host Lb. gasseri BfEL 92075 and the five non-inducible 
derivatives (Fig.77).The hybridization revealed that  L. gasseri and two of its five non-
inducible derivatives still harbored the temperate phage, while the other three non-
inducible derivatives were cured from the prophage. 
 
 
Fig. 78: Southern blot hybridization of phi Lbgas1, Lb. gasseri and its putatively cured 
derivatives. 
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6.2.10 Spot test  
To further confirm the prophage-curing derivatives were tested for sensitivity to phi 
Lbgas1in a spot test (Fig. 78). Clear spots appeared in the three derivatives of L. 
gasseri after infection with a dialyzed phi Lbgas1 lysate at dilutions up to 10-7. 
Plaques count indicated that the phage phi Lbgas1 lysate titer ranged from 108 to 109 
PFU
 
per ml. These results indicated the sensitivity of cured derivatives to phi Lbgas1.    
 
 
Fig. 79: Spot test for lysogenic strain and L. gasseri BfEL 92075 and one 
of its prophage-cured derivatives BfEL 92075-1 using phi Lbgas1  
 
During our study we faced difficulties to discover plaques formed by phi Lbgas1 on 
prophage-cured strain L. gasseri BfEL 92075-1. This may be due to low numbers of 
intact phages induced by MC treatment, as phi Lbgas1 seemed to have an abnormal 
tail structure (as seen in Fig 66). Most studies so far focused on improvement of 
plaque formation of virulent phages (Lillehaug, 1997). We optimized the conditions 
to obtain plaques with phi Lbgas1 on L. gasseri prophage-cured strain BfEL 92075-1 
(Fig.79). 
Our isolation of a prophage cured derivative of L. gasseri BfEL 92075 will be useful to 
eliminate the potential occurrence of virulent phages originating from phi Lbgas1. It 
was previously reported that virulent phage Ø FSV had derived from L. casei 
temperate phage Ø FSW (Shimizu-Kadota and Sakurai,1982).  Also, Lysogenic 
starters used in dairy products may be considered as a source of bacteriophage 
contamination on an industrial scale (Quiberoni et al., 2003; Shimizu-Kadota and 
Sakurai, 1982). Prophage curing improved L. gasseri under two aspects: i) it 
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eliminated the potential of virulent phages originating from phi Lbgas1, and ii) it 
eliminated the lysis gene from L. gasseri genome. we consider both aspects to be of 
advantage for a strain to be applied as probiotic. 
7 Summary and conclusion  
Lactobacilli have a worldwide industrial use as starters in the manufacturing of 
fermented dairy products. Moreover, some Lactobacillus strains have probiotic 
characteristics leading to increasing the use of lactobacilli in fermented food 
products. Increasing of probiotic lactobacilli in food products and nutritional 
supplements underscores the need to evaluate and correctly identify these useful 
bacteria.  
The aims of this study were to evaluate putative probiotic lactobacilli isolated from 
different sources as fermented milk products from Egypt and faeces from two new 
born children (twins) for establishment of probiotic strains, to clone and transform a 
bile salt hydrolase gene for genetic improvement of Lactobacillus strains to act as 
probiotics. Chapter I of the present study deals with for identification of LAB using 
molecular methods, like e.g. ARDRA, PFGE, and sequencing of the 16S rRNA gene, 
to achieve accurate identification for selection of probiotics. The objectives of chapter 
II were evaluation and characterization of 26 Lactobacillus strains through probiotic 
selection criteria (acid tolerance, bile salts resistance and antimicrobial activity). Also, 
a safety assessment of some Lactobacillus isolates was done. We report a survey of 
susceptibility of 26 Lactobacillus against 13 antibiotics including inhibitors of cell wall 
synthesis, protein and nucleic acid synthesis.  
Resistance to bile salts is one of the important criteria for selection and establishment 
of probiotic strains with good health benefits. Most of Lactobacillus strains showed 
some resistance to bile salts. In chapter III, we describe that conjugated bile salt-
hydrolase gene (cbh) is responsible for de-conjugation of bile acids. The cbh-gene 
and its regulatory sequences (promoter, ribosomal-binding site and terminator) from 
highly bile salts resistance Lactobacillus plantarum BfEL 92122 strain were amplified 
by PCR, cloned into E. coli vectors. The cbh was so strongly expressed in E. coli that 
transformants could be identified directly on indicator plates containing bile salts as a 
substrate, indicating that the cbh gene might be generally useable as a food-grade 
indicator gene. Cbh was recloned into several E. coli/Lactobacillus shuttle vectors. 
Electrotransformation of L. gasseri, L. casei and L. rahmnosus strains with these 
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recombinant plasmids and expression of cbh gene significantly improved resistance 
against ox-gall, glycodeoxycholic- and taurodeoxycholic acid. For probiotic bacteria to 
survive in the product and after consumption in the consumer’s gastrointestinal tract, 
inhibitory effect of bacteriophages and autolysis during industrial fermentation should 
be also considered. Therefore, chapter IV focused on lysogeny and autolysis of 
lactobacilli caused by bacteriophages or their enzymes and the characterization of a 
bacteriophage, phi Lbgas1.from L. gasseri. The establishment of a prophage cured 
derivative of this strain is reported. 
 Finally, we purpose for completion of characterization prospective in vivo studies on 
survival of Lactobacillus strain in animal models (like e.g. Gottingen minipigs). These 
studies may then form the basis for clinical evaluation the potential of the selected 
strains. health properties 
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8 Zusammenfassung  und Schlussfolgerungen 
Lactobacillen werden weltweit für die Herstellung fermentierter Lebensmittel benutzt. 
Neben ihrer Eignung als Säuerungsorganismen besitzen einige Stämme der 
Lactobacillen probiotische Eigenschaften. Um Bakterien als Probiotica nutzen zu 
können, ist eine korrekte Identifizierung und Evaluierung dieser Stämme 
unumgänglich. Das Ziel dieser Studie war es deshalb eventuell probiotische 
Lactobacillen-Stämme unterschiedlichster Herkunft (fermentierte Milchprodukte aus 
Ägypten, Fäzes von zwei neugeborenen Zwillingen) zu charakterisieren. Durch 
Klonierung und anschließender Übertragung  eines Gens für eine Gallensalz-
Hydrolase wurde zudem versucht, die probiotischen Eigenschaften einiger Stämme 
von Lactobacillen zu verbessern. 
Kapitel I dieser Arbeit befasst sich mit der exakten Identifizierung von 26 
Lactobacillus-Isolaten mittels molekularbiologischer Methoden wie ARDRA, PFGE 
und Sequenzierung von 16S rRNA Genen. 
In Kapitel II werden probiotische Eigenschaften dieser Stämme, wie Säure- und 
Gallensalztoleranz sowie deren antibakteriellen Aktivitäten und ihre Empfindlichkeiten 
gegenüber 13 Antibiotika beschrieben.  
Resistenz gegen Gallensalze ist ein wichtiges Kriterium für die Selektion und die 
Etablierung von probiotischen Stämmen. Die meisten der untersuchten Stämme 
zeigten eine gewisse Basistoleranz gegenüber Gallensalzen. Um dies zu erhöhen 
wurde das Gen cbh für eine Gallen salz hydrolase (conjugated bile salt hydrolase) 
aus Lactobacillus plantarum kloniert und in verschieden Lactobacillus-Spezies 
transformiert. Das cbh-Gen  und seine regulatorischen Sequenzen (Promotor, 
Ribosomen-Bindungsstelle, Terminator) wurden mittels PCR amplifiziert und in E. coli 
Klonierungsvektoren eingebaut. In E. coli wurde das Gen solchermaßen stark 
exprimiert, dass eine direkte Identifizierung transformierter Zellen möglich war. Das 
Gen eignet sich daher als ein „Food-Grade“ Indikator Gen. Das cbh-Gen wurde 
anschließend in verschieden E. coli/Lactobacillus Shuttle-Vektoren rekloniert und in 
verschiedenen Lactobacillus Spezies (L. casei, L,. gasseri, L. rhamnosus) exprimiert. 
Die Hydrolaseaktivität führte immer zu einer signifikanten Erhöhung der Resistent 
transformierter Stämme gegen Ochsengalle sowie Glyco- und Taurodeoxicholsäure. 
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Wichtig für das Überleben probiotischer Bakterien im Produkt und im 
Verdauungstrakt des Konsumenten sind deren Verhalten gegenüber Bakteriophagen 
sowie ihre autolytischen Aktivitäten. In Kapitel IV werden Fragen zur Lysogenie und 
Autolyse einiger Lactobacillen Stämme beantwortet. Im Rahmen dieser 
Untersuchungen wurde ein temperenter Bacteriophage, phiLbgas1, aus L. gasseri 
isoliert und charakterisiert, sowie ein prophagenfreies Derivat dieses Stammes 
hergestellt. 
Für eine abschließende Bewertung der untersuchten Stämme als Probioticum sind 
in-vivo Studien zum Überleben dieser Stämme in einem tierischen Modell wie z.B. in 
Göttinger Minischweinen geplant. Die Ergebnisse solcher Studien könnten die Basis 
bilden für eine anschließende Evaluierung potentieller, gesundheitsfördernder 
Eigenschaften ausgewählter Stämme.  
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